Citations

Citations to this article as recorded by  

• Factors Associated With Response to Rescue Therapy in Acute Severe Ulcerative Colitis
  Christopher F D Li Wai Suen, Dean Seah, Matthew C Choy, Peter De Cruz
  Inflammatory Bowel Diseases.2024; 30(8): 1389.     CrossRef
• Tofacitinib in Acute Severe Ulcerative Colitis (TACOS): A Randomized Controlled Trial
  Arshdeep Singh, Manjeet Kumar Goyal, Vandana Midha, Ramit Mahajan, Kirandeep Kaur, Yogesh Kumar Gupta, Dharmatma Singh, Namita Bansal, Ramandeep Kaur, Shivam Kalra, Omesh Goyal, Varun Mehta, Ajit Sood
  American Journal of Gastroenterology.2024; 119(7): 1365.     CrossRef
• Emergency subtotal colectomy rates in relation to anti-TNF therapy in inflammatory bowel disease patients: comparison of retrospective cohorts
  Saman Sajjadi, Rebecca Svensson Neufert, Emilia Ruhr, Sebastian Tryggmo, Jan Marsal, Pamela Buchwald
  Scandinavian Journal of Gastroenterology.2023; 58(1): 15.     CrossRef
• The role and prospect of tofacitinib in patients with ulcerative colitis
  Jun Lee
  Intestinal Research.2023; 21(1): 168.     CrossRef
• Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study
  Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim, Sang Hyoung Park
  Intestinal Research.2023; 21(2): 252.     CrossRef
• Rescue Therapies for Steroid-refractory Acute Severe Ulcerative Colitis: A Review
  Javier P Gisbert, María José García, María Chaparro
  Journal of Crohn's and Colitis.2023; 17(6): 972.     CrossRef
• The Efficacy of Currently Licensed Biologics for Treatment of Ulcerative Colitis: A Literature Review
  Humza Awan, Urooj Fatima, Ryan Eaw, Naomi Knox, Laith Alrubaiy
  Cureus.2023;[Epub]     CrossRef
• Reviewing not Homer’s Iliad, but “Kai Bao Ben Cao”: indigo dye—the past, present, and future
  Yusuke Yoshimatsu, Tomohisa Sujino, Takanori Kanai
  Intestinal Research.2023; 21(2): 174.     CrossRef
• Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease
  Yu Kyung Jun, Hyuk Yoon, Seong-Joon Koh, A Hyeon Kim, Kwang Woo Kim, Jun Won Park, Hyun Jung Lee, Hyoun Woo Kang, Jong Pil Im, Young Soo Park, Joo Sung Kim
  Intestinal Research.2023; 21(2): 244.     CrossRef
• Characteristics and Treatment Outcomes of Transition among Patients with Inflammatory Bowel Disease
  Eun Jin Yoo, Sang-Hoon Cho, Soo Jung Park, Tae Il Kim, Won Ho Kim, Jae Hee Cheon
  Yonsei Medical Journal.2023; 64(9): 541.     CrossRef
• CURRENT STATUS, PROBLEMS AND PROSPECTS OF ULCERATIVE COLITIS MEDICAL CORRECTION (LITERATURE REVIEW)
  T. O. Briukhanova, O. A. Nakonechna, O. V Babenko
  Bulletin of Problems Biology and Medicine.2023; 1(3): 28.     CrossRef
• Comparison of 1-Year Colectomy Risk Between the US and Korean Patients with Acute Severe Ulcerative Colitis: A Propensity Score Matching Analysis
  Eun Soo Kim, Kyeong Ok Kim, Byung Ik Jang, Eun Young Kim, Yoo Jin Lee, Hyun Seok Lee, Joon Seop Lee, Sung Kook Kim, Yun Jin Jung, Sang-Bum Kang, Manasi Agrawal, Ryan Ungaro, Jean-Frederic Colombel
  Digestive Diseases and Sciences.2022; 67(7): 2866.     CrossRef
• Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein (CRP)-lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy
  Danny Con, Bridgette Andrew, Steven Nicolaides, Daniel R van Langenberg, Abhinav Vasudevan
  Intestinal Research.2022; 20(1): 101.     CrossRef
• Impact of Immunosuppressive Therapy on the Performance of Latent Tuberculosis Screening Tests in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
  Chan Hyuk Park, Jung Ho Park, Yoon Suk Jung
  Journal of Personalized Medicine.2022; 12(3): 507.     CrossRef
• Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
  Jihye Park, Jae Hee Cheon
  The Korean Journal of Internal Medicine.2022; 37(5): 895.     CrossRef
• Oral beclomethasone dipropionate as an add-on therapy and response prediction in Korean patients with ulcerative colitis
  Kyuwon Kim, Hee Seung Hong, Kyunghwan Oh, Jae Yong Lee, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye, Sang Hyoung Park
  The Korean Journal of Internal Medicine.2022; 37(6): 1140.     CrossRef
• Progress in Diagnosis and Treatment of Ulcerative Colitis with Cytomegalovirus Infection
  海丽 吴
  Advances in Clinical Medicine.2022; 12(08): 7627.     CrossRef
• Viral Hepatitis in Patients with Inflammatory Bowel Disease
  Seung Hwan Shin, Sang Hyoung Park
  The Korean Journal of Gastroenterology.2022; 80(2): 51.     CrossRef
• Improvement in Medication Adherence after Pharmacist Intervention Is Associated with Favorable Clinical Outcomes in Patients with Ulcerative Colitis
  Jae Song Kim, Min Jung Geum, Eun Sun Son, Yun Mi Yu, Jae Hee Cheon, Kyeng Hee Kwon
  Gut and Liver.2022; 16(5): 736.     CrossRef
• Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Multicenter, Prospective, Postmarketing Surveillance Study
  Jongwook Yu, Soo Jung Park, Hyung Wook Kim, Yun Jeong Lim, Jihye Park, Jae Myung Cha, Byong Duk Ye, Tae Oh Kim, Hyun-Soo Kim, Hyun Seok Lee, Su Young Jung, Youngdoe Kim, Chang Hwan Choi
  Gut and Liver.2022; 16(5): 764.     CrossRef
• Physician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION study
  Yehyun Park, Chang Hwan Choi, Hyun Soo Kim, Hee Seok Moon, Do Hyun Kim, Jin Ju Kim, Dennis Teng, Dong Il Park
  Intestinal Research.2022; 20(4): 452.     CrossRef
• Optimal Management of Acute Severe Ulcerative Colitis (ASUC): Challenges and Solutions
  Tom Holvoet, Triana Lobaton, Pieter Hindryckx
  Clinical and Experimental Gastroenterology.2021; Volume 14: 71.     CrossRef
• Pharmacogenetics-based personalized treatment in patients with inflammatory bowel disease: A review
  Ji Young Chang, Jae Hee Cheon
  Precision and Future Medicine.2021; 5(4): 151.     CrossRef

Citations

Citations to this article as recorded by  

• Post-inflammatory Abdominal Pain in Patients with Inflammatory Bowel Disease During Remission: A Comprehensive Review
  Kazuya Takahashi, Iman Geelani Khwaja, Jocelyn Rachel Schreyer, David Bulmer, Madusha Peiris, Shuji Terai, Qasim Aziz
  Crohn's & Colitis 360.2021;[Epub]     CrossRef
• Two cases in which tofacitinib effectively treated both ulcerative colitis and alopecia areata
  Oki Kikuchi, Daisuke Saito, Miki Miura, Haruka Wada, Ryo Ozaki, Sotaro Tokunaga, Shintaro Minowa, Masahiro Fukuyama, Tatsuya Mitsui, Akihito Sakuraba, Mari Hayashida, Jun Miyoshi, Minoru Matsuura, Manabu Ohyama, Tadakazu Hisamatsu
  Clinical Journal of Gastroenterology.2020; 13(5): 788.     CrossRef
• Tuberculosis and targeted synthetic or biologic DMARDs, beyond tumor necrosis factor inhibitors
  Gerasimos Evangelatos, Vasiliki Koulouri, Alexios Iliopoulos, George E Fragoulis
  Therapeutic Advances in Musculoskeletal Disease.2020;[Epub]     CrossRef
• RETRACTED: Crystal structure, anti-cervical cancer activity and docking studies of a new heterocycles compound
  Peng Li, Xin Ge, Hong-Li Wu
  Main Group Chemistry.2019; 18(2): 63.     CrossRef

In addition to genetic and epigenetic factors, various environmental factors, including diet, play important roles in the development of colorectal cancer (CRC). Recently, there is increasing interest in the intestinal microbiota as an environmental risk factor for CRC, because diet also influences the composition of the intestinal microbiota. The human intestinal microbiota comprises about 100 trillion microbes. This microbiome thrives on undigested dietary residues in the intestinal lumen and produces various metabolites. It is well known that the dietary risk factors for CRC are mediated by dysbiosis of the intestinal microbiota and their metabolites. In this review, we describe the bacterial taxa associated with CRC, including Fusobacterium nucleatum, enterotoxigenic Bacteroides fragilis, Escherichia coli, and butyrate-producing bacteria. We also discuss the host-diet interaction in colorectal carcinogenesis.

Citations

Citations to this article as recorded by  

• Composition of the colon microbiota in the individuals with inflammatory bowel disease and colon cancer
  Ceren Acar, Sibel Kucukyildirim Celik, H. Ozgur Ozdemirel, Beril Erdem Tuncdemir, Saadet Alan, Hatice Mergen
  Folia Microbiologica.2024; 69(2): 333.     CrossRef
• Role of Probiotics against Human Cancers, Inflammatory Diseases, and Other Complex Malignancies
  Hammad Naeem, Hammad Ul Hassan, Muhammad Shahbaz, Muhammad Imran, Anjuman Gul Memon, Ammarah Hasnain, Shamas Murtaza, Suliman A. Alsagaby, Waleed Al Abdulmonem, Muzzamal Hussain, Mohamed A. Abdelgawad, Mohammed M. Ghoneim, Entessar Al Jbawi, Rafik Balti
  Journal of Food Biochemistry.2024; 2024: 1.     CrossRef
• The State-of-the-Art Mechanisms and Antitumor Effects of Somatostatin in Colorectal Cancer: A Review
  Aldona Kasprzak, Agnieszka Geltz
  Biomedicines.2024; 12(3): 578.     CrossRef
• Association of gut microbiome with immune microenvironment in surgically treated colorectal cancer patients
  Nayoung Han, Hee Jin Chang, Hyun Yang Yeo, Byung Chang Kim, Bun Kim, Sung Chan Park, Jeongseon Kim, Ji Won Park, Jae Hwan Oh
  Pathology.2024; 56(4): 528.     CrossRef
• The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development
  Hadas Ashkenazi-Preiser, Or Reuven, Atara Uzan-Yulzari, Sharon Komisarov, Roy Cirkin, Sondra Turjeman, Carmel Even, Nira Twaik, Kerem Ben-Meir, Ivan Mikula, Leonor Cohen-Daniel, Yaron Meirow, Eli Pikarsky, Yoram Louzoun, Omry Koren, Michal Baniyash
  Cancer Research Communications.2024; 4(4): 1063.     CrossRef
• A Potential Role of Xenometabolites as Nutraceutical: A Concurrent Review
  Sunanda Biswas, Ali Imran, Fakhar Islam, Muhammad Umair Arshad, Iqra Aslam, Mohd Asif Shah, Umber Shehzadi, Ifrah Usman, zza Faiz UL Rasool, Safura Aslam
  Current Research in Nutrition and Food Science Journal.2024; 12(1): 20.     CrossRef
• TLR4/NF-kB/β-Catenin/TGF-β pathways in Salmonella AvrA related-Colorectal Cancer Tumorigenesis
  Bogi Pratomo Wibowo, Handono Kalim, Husnul Khotimah, Hidayat Sujuti, Ettie Rukmigarsari
  Research Journal of Pharmacy and Technology.2024; : 2597.     CrossRef
• Association of Helicobacter pylori infection with colorectal polyps/adenomas: A single-center cross-sectional study
  Lan Chen, Rongrong Cao, Jie Han, Honglu Yu, Yingchao Li, Xiaomin Wang, Jiang Chen, Xingshun Qi
  Cancer Epidemiology.2024; 92: 102626.     CrossRef
• Interactions between toll‐like receptors signaling pathway and gut microbiota in host homeostasis
  Luping Chen, Linfang Zhang, Hua Hua, Li Liu, Yuejian Mao, Ruirui Wang
  Immunity, Inflammation and Disease.2024;[Epub]     CrossRef
• Collective neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio symbolizes a new prognostic factor in the survival of gastric cancer patients
  Sareh Mohammadi, Zeinab Veisi, Mohammad Moazeni, Soleiman Kheiri, Zahra Lorigooini, Roholah Masomi
  Journal of Shahrekord University of Medical Sciences.2024; 26(2): 51.     CrossRef
• Autophagy and the Insulin-like Growth Factor (IGF) System in Colonic Cells: Implications for Colorectal Neoplasia
  Aldona Kasprzak
  International Journal of Molecular Sciences.2023; 24(4): 3665.     CrossRef
• The Colorectal Cancer Gut Environment Regulates Activity of the Microbiome and Promotes the Multidrug Resistant Phenotype of ESKAPE and Other Pathogens
  Matthew T. F. Lamaudière, Ramesh Arasaradnam, Gareth D. Weedall, Igor Y. Morozov, Vincent B. Young
  mSphere.2023;[Epub]     CrossRef
• Bacteroides fragilis Toxin Induces Cleavage and Proteasome Degradation of E-cadherin in Human Breast Cancer Cell Lines BT-474 and MCF7
  Da-Hye KANG, Sang-Hyeon YOO, Ju-Eun HONG, Ki-Jong RHEE
  Korean Journal of Clinical Laboratory Science.2023; 55(1): 37.     CrossRef
• Editorial: Targeting the microbiota to attenuate chronic inflammation
  Elena Moreno, Marius Trøseid, Ivan Vujkovic-Cvijin, Giulia Marchetti, Laura Martín-Pedraza, Sergio Serrano-Villar
  Frontiers in Immunology.2023;[Epub]     CrossRef
• Anti-tumour effect of Huangqin Decoction on colorectal cancer mice through microbial butyrate mediated PI3K/Akt pathway suppression
  Jia-Jie Zhu, Hai-Yan Liu, Liang-Jun Yang, Zheng Fang, Rui Fu, Jia-Bin Chen, Shan Liu, Bao-Ying Fei
  Journal of Medical Microbiology .2023;[Epub]     CrossRef
• Disease‐associated gut microbiome and critical metabolomic alterations in patients with colorectal cancer
  Hongze Zhang, Kai Jin, Kunlong Xiong, Wenwen Jing, Zhen Pang, Meng Feng, Xunjia Cheng
  Cancer Medicine.2023; 12(14): 15720.     CrossRef
• Cellular and Molecular Mechanisms of the Tumor Stroma in Colorectal Cancer: Insights into Disease Progression and Therapeutic Targets
  Nikolay Shakhpazyan, Liudmila Mikhaleva, Arkady Bedzhanyan, Zarina Gioeva, Nikolay Sadykhov, Alexander Mikhalev, Dmitri Atiakshin, Igor Buchwalow, Markus Tiemann, Alexander Orekhov
  Biomedicines.2023; 11(9): 2361.     CrossRef
• Impact of Diet on Colorectal Cancer Progression and Prevention: From Nutrients to Neoplasms
  Sang Hoon Kim, Dong Hwan Park, Yun Jeong Lim
  The Korean Journal of Gastroenterology.2023; 82(2): 73.     CrossRef
• Microbial dysbiosis and epigenetics modulation in cancer development – A chemopreventive approach
  Shafiul Haque, Ritu Raina, Nazia Afroze, Arif Hussain, Ahmad Alsulimani, Vineeta Singh, Bhartendu Nath Mishra, Sanjana Kaul, Ravindra Nath Kharwar
  Seminars in Cancer Biology.2022; 86: 666.     CrossRef
• A Brief look at antitumor effects of doxycycline in the treatment of colorectal cancer and combination therapies
  Kimia Ghasemi, Kosar Ghasemi
  European Journal of Pharmacology.2022; 916: 174593.     CrossRef
• Association Between H. pylori Infection and Colorectal Polyps: A Meta-Analysis of Observational Studies
  Depeng Lu, Mingyu Wang, Xiquan Ke, Qiangwu Wang, Jianchao Wang, Dapeng Li, Meng Wang, Qizhi Wang
  Frontiers in Medicine.2022;[Epub]     CrossRef
• The role of microbiome in colorectal carcinogenesis and its clinical potential as a target for cancer treatment
  Sang Hoon Kim, Yun Jeong Lim
  Intestinal Research.2022; 20(1): 31.     CrossRef
• A systemic review of the role of enterotoxic Bacteroides fragilis in colorectal cancer
  Nancy Scott, Emma Whittle, Patricio Jeraldo, Nicholas Chia
  Neoplasia.2022; 29: 100797.     CrossRef
• Ficus dubia Latex Extract Induces Cell Cycle Arrest and Apoptosis by Regulating the NF-κB Pathway in Inflammatory Human Colorectal Cancer Cell Lines
  Rentong Hu, Weerachai Chantana, Pornsiri Pitchakarn, Subhawat Subhawa, Bhanumas Chantarasuwan, Piya Temviriyanukul, Teera Chewonarin
  Cancers.2022; 14(11): 2665.     CrossRef
• Potential Impacts of Prebiotics and Probiotics on Cancer Prevention
  Saptadip Samanta
  Anti-Cancer Agents in Medicinal Chemistry.2022; 22(4): 605.     CrossRef
• Archaeome in Colorectal Cancer: High Abundance of Methanogenic Archaea in Colorectal Cancer Patients
  Hosseinali Abdi, Dor Mohammad Kordi-Tamandani, Milad Lagzian, Alireza Bakhshipour
  International Journal of Cancer Management.2022;[Epub]     CrossRef
• Escherichia coli and Colorectal Cancer: Unfolding the Enigmatic Relationship
  Roghayeh Nouri, Alka Hasani, Kourosh Masnadi Shirazi, Mohammad Reza Alivand, Bita Sepehri, Simin Sotoodeh, Fatemeh Hemmati, Mohammad Ahangarzadeh Rezaee
  Current Pharmaceutical Biotechnology.2022; 23(10): 1257.     CrossRef
• Synthesis and Evaluation of Some New 4H-Pyran Derivatives as Antioxidant, Antibacterial and Anti-HCT-116 Cells of CRC, with Molecular Docking, Antiproliferative, Apoptotic and ADME Investigations
  Nahed N. E. El-Sayed, Magdi E. A. Zaki, Sami A. Al-Hussain, Abir Ben Bacha, Malika Berredjem, Vijay H. Masand, Zainab M. Almarhoon, Hanaa S. Omar
  Pharmaceuticals.2022; 15(7): 891.     CrossRef
• Inflammatory bowel disease in Korea: epidemiology and pathophysiology
  Jung Won Lee, Chang Soo Eun
  The Korean Journal of Internal Medicine.2022; 37(5): 885.     CrossRef
• The Dark Side of Iron: The Relationship between Iron, Inflammation and Gut Microbiota in Selected Diseases Associated with Iron Deficiency Anaemia—A Narrative Review
  Ida J. Malesza, Joanna Bartkowiak-Wieczorek, Jakub Winkler-Galicki, Aleksandra Nowicka, Dominika Dzięciołowska, Marta Błaszczyk, Paulina Gajniak, Karolina Słowińska, Leszek Niepolski, Jarosław Walkowiak, Edyta Mądry
  Nutrients.2022; 14(17): 3478.     CrossRef
• Cholecystectomy-induced secondary bile acids accumulation ameliorates colitis through inhibiting monocyte/macrophage recruitment
  Yun Liu, Jun Xu, Xinhua Ren, Yu Zhang, Ziliang Ke, Jianhua Zhou, Yang Wang, Yifan Zhang, Yulan Liu
  Gut Microbes.2022;[Epub]     CrossRef
• Wenzi Jiedu Recipe ameliorates colorectal cancer by remodeling the gut microbiota and tumor microenvironment
  Wenli Qiu, Tianqing Sang, Haibin Chen, Hongli Zhou, Zhongqiu Wang, Hongguang Zhou
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Roles of Gut Microbiota in Colorectal Carcinogenesis Providing a Perspective for Early Diagnosis and Treatment
  Roghayeh Nouri, Alka Hasani, Mohammad Asgharzadeh, Fatemeh Yeganeh Sefidan, Fatemeh Hemmati, Mohammad Ahangarzadeh Rezaee
  Current Pharmaceutical Biotechnology.2022; 23(13): 1569.     CrossRef
• Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma
  Wei Jia, Cynthia Rajani, Hongxi Xu, Xiaojiao Zheng
  Protein & Cell.2021; 12(5): 374.     CrossRef
• Toll-like receptor 4 prevents AOM/DSS-induced colitis-associated colorectal cancer in Bacteroides fragilis gnotobiotic mice
  Yen-Peng Lee, Wen-Ching Huang, Tien-Jen Lin, Chien-Chao Chiu, Yu-Chih Wang, Yi-Hsun Chen, Shao-Wen Hung, Hsiao-Li Chuang, Ter-Hsin Chen
  Human & Experimental Toxicology.2021; 40(4): 622.     CrossRef
• Gut microbiota influence tumor development and Alter interactions with the human immune system
  Yanshan Ge, Xinhui Wang, Yali Guo, Junting Yan, Aliya Abuduwaili, Kasimujiang Aximujiang, Jie Yan, Minghua Wu
  Journal of Experimental & Clinical Cancer Research.2021;[Epub]     CrossRef
• The Distinctive Serum Metabolomes of Gastric, Esophageal and Colorectal Cancers
  Zhenxing Ren, Cynthia Rajani, Wei Jia
  Cancers.2021; 13(4): 720.     CrossRef
• Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer
  Yongshun Ma, Yao Zhang, Houxiang Jiang, Shixin Xiang, Yueshui Zhao, Mintao Xiao, Fukuan Du, Huijiao Ji, Parham Jabbarzadeh Kaboli, Xu Wu, Mingxing Li, Qinglian Wen, Jing Shen, Zhongming Yang, Jing Li, Zhangang Xiao
  Frontiers in Cellular and Infection Microbiology.2021;[Epub]     CrossRef
• Analysis of the intestinal microbiome in colorectal cancer
  B I Gataullin, I G Gataullin, Nguyen Thi Nga, A I Kolpakov, O N Ilinskaya
  Kazan medical journal.2021; 102(2): 185.     CrossRef
• Astragalin Inhibits the Proliferation and Migration of Human Colon Cancer HCT116 Cells by Regulating the NF-κB Signaling Pathway
  Min Yang, Wen-Yun Li, Jing Xie, Zi-Lin Wang, Yan-Long Wen, Cun-Chao Zhao, Liang Tao, Ling-Fei Li, Yang Tian, Jun Sheng
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Temporal metabolic response yields a dynamic biosignature of inflammation
  Jesse T. Peach, Stephanie M. Wilson, Logan D. Gunderson, Lizzi Frothingham, Tan Tran, Seth T. Walk, Carl J. Yeoman, Brian Bothner, Mary P. Miles
  iScience.2021; 24(8): 102817.     CrossRef
• Colorectal Cancer Stage-Specific Fecal Bacterial Community Fingerprinting of the Taiwanese Population and Underpinning of Potential Taxonomic Biomarkers
  Chuan-Yin Fang, Jung-Sheng Chen, Bing-Mu Hsu, Bashir Hussain, Jagat Rathod, Kuo-Hsin Lee
  Microorganisms.2021; 9(8): 1548.     CrossRef
• Association of Helicobacter pylori infection with colorectal adenoma in the Chinese urban population: A cross-sectional study
  Lingyu Shen, Rongwen Bian, Wei Wang, Junning Zhao
  Microbial Pathogenesis.2021; 158: 105111.     CrossRef
• Multi-scale network targeting: A holistic systems-biology approach to cancer treatment
  Doru Paul, Natalia L. Komarova
  Progress in Biophysics and Molecular Biology.2021; 165: 72.     CrossRef
• Lipopolysaccharides Enhance Epithelial Hyperplasia and Tubular Adenoma in Intestine-Specific Expression of krasV12 in Transgenic Zebrafish
  Jeng-Wei Lu, Yuxi Sun, Pei-Shi Angelina Fong, Liang-In Lin, Dong Liu, Zhiyuan Gong
  Biomedicines.2021; 9(8): 974.     CrossRef
• High frequency of enterotoxigenic Bacteroides fragilis and Enterococcus faecalis in the paraffin-embedded tissues of Iranian colorectal cancer patients
  Nasibeh Khodaverdi, Habib Zeighami, Ahmad Jalilvand, Fakhri Haghi, Negar Hesami
  BMC Cancer.2021;[Epub]     CrossRef
• Function of BCLAF1 in human disease (Review)
  Zongdong Yu, Jie Zhu, Haibiao Wang, Hong Li, Xiaofeng Jin
  Oncology Letters.2021;[Epub]     CrossRef
• Association Between Carotid Ultrasonography Findings and Colorectal Adenoma in Asymptomatic Adults
  Jeongseok Kim, Ji Young Lee, Nam Seok Ham, Eun Hye Oh, Hye-Sook Chang, Hyewon Park, Yoon Suh Do, Sung Wook Hwang, Dong-Hoon Yang, Jae Won Choe, Jeong-Sik Byeon
  Digestive Diseases and Sciences.2020; 65(6): 1816.     CrossRef
• Dietary Xanthan Gum Alters Antibiotic Efficacy against the Murine Gut Microbiota and Attenuates Clostridioides difficile Colonization
  Matthew K. Schnizlein, Kimberly C. Vendrov, Summer J. Edwards, Eric C. Martens, Vincent B. Young, Katherine McMahon
  mSphere.2020;[Epub]     CrossRef
• Enterotoxigenic Bacteroides fragilis: A Possible Etiological Candidate for Bacterially-Induced Colorectal Precancerous and Cancerous Lesions
  Samin Zamani, Reza Taslimi, Akram Sarabi, Seyedesomaye Jasemi, Leonardo A. Sechi, Mohammad Mehdi Feizabadi
  Frontiers in Cellular and Infection Microbiology.2020;[Epub]     CrossRef
• Risk for Colorectal Neoplasia in Patients With Helicobacter pylori Infection: A Systematic Review and Meta-analysis
  Da Sol Choi, Seung In Seo, Woon Geon Shin, Chan Hyuk Park
  Clinical and Translational Gastroenterology.2020; 11(2): e00127.     CrossRef
• Metaproteomics characterizes human gut microbiome function in colorectal cancer
  Shuping Long, Yi Yang, Chengpin Shen, Yiwen Wang, Anmei Deng, Qin Qin, Liang Qiao
  npj Biofilms and Microbiomes.2020;[Epub]     CrossRef
• Gut commensal bacteria, Paneth cells and their relations to radiation enteropathy
  Yan-Li Gao, Li-Hong Shao, Li-Hua Dong, Peng-Yu Chang
  World Journal of Stem Cells.2020; 12(3): 188.     CrossRef
• Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2′-O-methylation via NOP58 recruitment in colorectal cancer
  Huizhe Wu, Wenyan Qin, Senxu Lu, Xiufang Wang, Jing Zhang, Tong Sun, Xiaoyun Hu, Yalun Li, Qiuchen Chen, Yuanhe Wang, Haishan Zhao, Haiyan Piao, Rui Zhang, Minjie Wei
  Molecular Cancer.2020;[Epub]     CrossRef
• The Influence of Caerulomycin A on the Intestinal Microbiota in SD Rats
  Hongwei Zhang, Mengmeng Lan, Guodong Cui, Weiming Zhu
  Marine Drugs.2020; 18(5): 277.     CrossRef
• Influence of Iron on the Gut Microbiota in Colorectal Cancer
  Oliver Phipps, Hafid O. Al-Hassi, Mohammed N. Quraishi, Aditi Kumar, Matthew J. Brookes
  Nutrients.2020; 12(9): 2512.     CrossRef
• Multiomics Study of Gut Bacteria and Host Metabolism in Irritable Bowel Syndrome and Depression Patients
  Congmin Xu, Qiong Jia, Lu Zhang, Zhe Wang, Shiwei Zhu, Xiaoqi Wang, Yixuan Liu, Mo Li, Jingjing Zhang, Xiangqun Wang, Jindong Zhang, Qinghua Sun, Kun Wang, Huaiqiu Zhu, Liping Duan
  Frontiers in Cellular and Infection Microbiology.2020;[Epub]     CrossRef
• The Human OncoBiome Database: A Database of Cancer Microbiome Datasets
  Nadia, Jayashree Ramana
  Current Bioinformatics.2020; 15(5): 472.     CrossRef
• Microbiota and gastrointestinal cancer
  Meng-Tzu Weng, Yu-Tse Chiu, Ping-Ya Wei, Chien-Wei Chiang, Huei-Ling Fang, Shu-Chen Wei
  Journal of the Formosan Medical Association.2019; 118: S32.     CrossRef
• Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models
  Susan J. Robertson, Paul Lemire, Heather Maughan, Ashleigh Goethel, Williams Turpin, Larbi Bedrani, David S. Guttman, Kenneth Croitoru, Stephen E. Girardin, Dana J. Philpott
  Cell Reports.2019; 27(6): 1910.     CrossRef
• Periodontitis is associated with an increased risk for proximal colorectal neoplasms
  Gun Woo Kim, Young-Sang Kim, Soo Hyun Lee, Seung Geon Park, Duk Hwan Kim, Joo Young Cho, Ki Baik Hahm, Sung Pyo Hong, Jun-Hwan Yoo
  Scientific Reports.2019;[Epub]     CrossRef
• Physical Activity and Inflammation Phenotype Conversion
  Mary P. Miles, Stephanie Wilson, Carl J. Yeoman
  Journal of Clinical Exercise Physiology.2019; 8(2): 64.     CrossRef
• The clinical application of fruquintinib on colorectal cancer
  Zhongguang Chen, Lili Jiang
  Expert Review of Clinical Pharmacology.2019; 12(8): 713.     CrossRef
• Study Insights into Gastrointestinal Cancer through the Gut Microbiota
  Fanli Kong, Yi Cai
  BioMed Research International.2019; 2019: 1.     CrossRef
• Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies
  Fausto Petrelli, Michele Ghidini, Antonio Ghidini, Gianluca Perego, Mary Cabiddu, Shelize Khakoo, Emanuela Oggionni, Chiara Abeni, Jens Claus Hahne, Gianluca Tomasello, Alberto Zaniboni
  Cancers.2019; 11(8): 1174.     CrossRef
• Functional polymorphisms of the lncRNA H19 promoter region contribute to the cancer risk and clinical outcomes in advanced colorectal cancer
  Wenyan Qin, Xiaodong Wang, Yilin Wang, Yalun Li, Qiuchen Chen, Xiaoyun Hu, Zhikun Wu, Pengfei Zhao, Shanqiong Li, Haishan Zhao, Weifan Yao, Jian Ding, Minjie Wei, Huizhe Wu
  Cancer Cell International.2019;[Epub]     CrossRef
• The association between fecal enterotoxigenic B. fragilis with colorectal cancer
  Fakhri Haghi, Elshan Goli, Bahman Mirzaei, Habib Zeighami
  BMC Cancer.2019;[Epub]     CrossRef
• Fusobacterium nucleatum and the Immune System in Colorectal Cancer
  Elena Monica Borroni, Dorina Qehajaj, Floriana Maria Farina, Daniel Yiu, Robert S. Bresalier, Maurizio Chiriva-Internati, Leonardo Mirandola, Sanja Štifter, Luigi Laghi, Fabio Grizzi
  Current Colorectal Cancer Reports.2019; 15(5): 149.     CrossRef
• Non-alcoholic fatty liver disease and colorectal cancer: A marker of risk or common causation?
  Niki Katsiki, Dimitri P. Mikhailidis, Christos Mantzoros
  Metabolism.2018; 87: A10.     CrossRef

Citations

Citations to this article as recorded by  

• Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: a KASID multicenter cohort study
  Seung Hwan Shin, Kyunghwan Oh, Sung Noh Hong, Jungbok Lee, Shin Ju Oh, Eun Soo Kim, Soo-Young Na, Sang-Bum Kang, Seong-Joon Koh, Ki Bae Bang, Sung-Ae Jung, Sung Hoon Jung, Kyeong Ok Kim, Sang Hyoung Park, Suk-Kyun Yang, Chang Hwan Choi, Byong Duk Ye
  Therapeutic Advances in Gastroenterology.2023; 16: 175628482311541.     CrossRef
• Factors predicting clinical and endoscopic remission with placebo therapy in East Asian patients with ulcerative colitis: a systematic review and meta-analysis
  Jian Zeng, Zhong Wang, Xiao-Jun Yang
  European Journal of Clinical Pharmacology.2022; 78(7): 1069.     CrossRef
• Personalized medicine in inflammatory bowel disease: Perspectives on Asia
  Su Hyun Park, Sang Hyoung Park
  Journal of Gastroenterology and Hepatology.2022; 37(8): 1434.     CrossRef
• Safety and efficacy of long‐term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open
  Katsuyoshi Matsuoka, Tadakazu Hisamatsu, Hyo Jong Kim, Byong Duk Ye, Shoko Arai, Masato Hoshi, Hirotoshi Yuasa, Junichi Tabira, Shigeyuki Toyoizumi, Nanzhi Shi, Joon‐suk Woo, Toshifumi Hibi
  Journal of Gastroenterology and Hepatology.2022; 37(10): 1884.     CrossRef
• Management of inflammatory bowel disease beyond tumor necrosis factor inhibitors: novel biologics and small-molecule drugs
  Soo-Young Na, You Sun Kim
  The Korean Journal of Internal Medicine.2022; 37(5): 906.     CrossRef
• Tofacitinib, the First Oral Janus Kinase Inhibitor Approved for Adult Ulcerative Colitis
  Brittany N. Palasik, Hongmei Wang
  Journal of Pharmacy Practice.2021; 34(6): 913.     CrossRef
• Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia
  Shu-Chen Wei, Jose Sollano, Yee Tak Hui, Wei Yu, Paul V. Santos Estrella, Lyndon John Q. Llamado, Nana Koram
  Expert Review of Gastroenterology & Hepatology.2021; 15(3): 275.     CrossRef
• Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis
  Toshifumi Hibi, Isao Kamae, Philippe Pinton, Lyann Ursos, Ryuichi Iwakiri, Greg Hather, Haridarshan Patel
  Intestinal Research.2021; 19(1): 53.     CrossRef
• Efficacy and safety of ustekinumab in East Asian patients with moderately to severely active ulcerative colitis: a subpopulation analysis of global phase 3 induction and maintenance studies (UNIFI)
  Tadakazu Hisamatsu, Hyo Jong Kim, Satoshi Motoya, Yasuo Suzuki, Yoshifumi Ohnishi, Noriyuki Fujii, Nobuko Matsushima, Richuan Zheng, Colleen W. Marano
  Intestinal Research.2021; 19(4): 386.     CrossRef
• Post-inflammatory Abdominal Pain in Patients with Inflammatory Bowel Disease During Remission: A Comprehensive Review
  Kazuya Takahashi, Iman Geelani Khwaja, Jocelyn Rachel Schreyer, David Bulmer, Madusha Peiris, Shuji Terai, Qasim Aziz
  Crohn's & Colitis 360.2021;[Epub]     CrossRef
• Multiple esophageal ulcers due to tofacitinib 10 mg twice daily for ulcerative colitis
  Keiichi Tominaga, Mimari Kanazawa, Kazuhiro Takenaka, Takanao Tanaka, Takeshi Sugaya, Koh Fukushi, Yuka Takagi, Kazunori Nagashima, Keiichiro Abe, Naoya Izawa, Kohei Tsuchida, Makoto Iijima, Kenichi Goda, Hidetsugu Yamagishi, Atsushi Irisawa
  Clinical Journal of Gastroenterology.2020; 13(3): 340.     CrossRef
• Interleukin 23 and autoimmune diseases: current and possible future therapies
  Ahmad Ismail Khaled Abdo, Gee Jun Tye
  Inflammation Research.2020; 69(5): 463.     CrossRef
• A Case of Lung Abscess Caused by Double Immunosuppressive Therapy to Treat Ulcerative Colitis
  Keiichi Tominaga, Mimari Kanazawa, Takanao Tanaka, Shunsuke Kojimahara, Takeshi Sugaya, Shoko Watanabe, Akira Yamamiya, Yuichi Majima, Makoto Iijima, Kenichi Goda, Atsushi Irisawa
  Medicina.2020; 56(11): 595.     CrossRef
• Inhibidores de la vía de señalización JAK-STAT en el tratamiento de las enfermedades inmunomediadas
  José M. Serra López-Matencio, Alberto Morell Baladrón, Santos Castañeda
  Medicina Clínica.2019; 152(9): 353.     CrossRef
• Interleukin-13: A promising therapeutic target for autoimmune disease
  Yan-Mei Mao, Chan-Na Zhao, Jing Leng, Rui-Xue Leng, Dong-Qing Ye, Song Guo Zheng, Hai-Feng Pan
  Cytokine & Growth Factor Reviews.2019; 45: 9.     CrossRef
• JAK-STAT inhibitors for the treatment of immunomediated diseases
  José M. Serra López-Matencio, Alberto Morell Baladrón, Santos Castañeda
  Medicina Clínica (English Edition).2019; 152(9): 353.     CrossRef
• Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience
  Ferdinando D’Amico, Tommaso Lorenzo Parigi, Gionata Fiorino, Laurent Peyrin-Biroulet, Silvio Danese
  Therapeutic Advances in Gastroenterology.2019; 12: 175628481984863.     CrossRef
• Inhibitors of the Janus Kinases
  Elisabetta Antonelli, Gabriele Torti, Gabrio Bassotti
  Journal of Clinical Gastroenterology.2019; 53(9): 635.     CrossRef
• Novel oral-targeted therapies for mucosal healing in ulcerative colitis
  Elisabetta Antonelli, Vincenzo Villanacci, Gabrio Bassotti
  World Journal of Gastroenterology.2018; 24(47): 5322.     CrossRef

Because anti-tumor necrosis factor (anti-TNF) therapy has become increasingly popular in many Asian countries, the risk of developing active tuberculosis (TB) among anti-TNF users may raise serious health problems in this region. Thus, the Asian Organization for Crohn's and Colitis and the Asia Pacific Association of Gastroenterology have developed a set of consensus statements about risk assessment, detection and prevention of latent TB infection, and management of active TB infection in patients with inflammatory bowel disease (IBD) receiving anti-TNF treatment. Twenty-three consensus statements were initially drafted and then discussed by the committee members. The quality of evidence and the strength of recommendations were assessed by using the Grading of Recommendations Assessment, Development, and Evaluation methodology. Web-based consensus voting was performed by 211 IBD specialists from 9 Asian countries concerning each statement. A consensus statement was accepted if at least 75% of the participants agreed. Part 1 of the statements comprised 2 parts: risk of TB infection Recommendaduring anti-TNF therapy, and screening for TB infection prior to commencing anti-TNF therapy. These consensus statements will help clinicians optimize patient outcomes by reducing the morbidity and mortality related to TB infections in patients with IBD receiving anti-TNF treatment.

Citations

Citations to this article as recorded by  

• Risk of Tuberculosis and Hepatitis B Reactivation in Patients With Crohn’s Disease on Ustekinumab: A Nationwide Real-World Study
  Rongbei Liu, Zhilun Li, Lingna Ye, Jing Hu, Jian Tang, Baili Chen, Xiuli Chen, Bei Tan, Yubei Gu, Chen Xie, Chunhui Ouyang, Xiaomei Song, Fan Li, Yanyun Fan, Haixia Ren, Liangru Zhu, Min Chen, Wenyu Jiang, Qian Cao
  Inflammatory Bowel Diseases.2024; 30(1): 45.     CrossRef
• (Re-)introduction of TNF antagonists and JAK inhibitors in patients with previous tuberculosis: a systematic review
  Thomas Theo Brehm, Maja Reimann, Niklas Köhler, Christoph Lange
  Clinical Microbiology and Infection.2024; 30(8): 989.     CrossRef
• Ten missteps in the management of inflammatory bowel disease in Asia: An expert report by the Asian Pacific Association of Gastroenterology Working Group on Inflammatory Bowel Disease
  Vineet Ahuja, Ida Hilmi, Byong Duk Ye, Khoon Lin Ling, Siew C. Ng, Rupert W. Leong, Peeyush Kumar, Xin Hui Khoo, Govind K. Makharia, Jose Sollano, Pises Pisespongsa, Nazri Mustaffa, Rupa Banerjee, Alex Hwong‐Ruey Leow, Raja Affendi Raja Ali, Sai Wei Chuah
  Journal of Gastroenterology and Hepatology.2024; 39(8): 1500.     CrossRef
• Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
  Soo-Young Na, Chang Hwan Choi, Eun Mi Song, Ki Bae Bang, Sang Hyoung Park, Eun Soo Kim, Jae Jun Park, Bora Keum, Chang Kyun Lee, Bo-In Lee, Seung-Bum Ryoo, Seong-Joon Koh, Miyoung Choi, Joo Sung Kim
  Intestinal Research.2023; 21(1): 61.     CrossRef
• Thiopurines are an independent risk factor for active tuberculosis in inflammatory bowel disease patients
  Flora Maria Lorenzo Fortes, Raquel Rocha, Genoile Oliveira Santana
  World Journal of Gastroenterology.2023; 29(9): 1536.     CrossRef
• Bronchoesophageal fistula in a patient with Crohn’s disease receiving anti-tumor necrosis factor therapy
  Kyunghwan Oh, Kee Don Choi, Hyeong Ryul Kim, Tae Sun Shim, Byong Duk Ye, Suk-Kyun Yang, Sang Hyoung Park
  Clinical Endoscopy.2023; 56(2): 239.     CrossRef
• Miliary Tuberculosis in a Patient With Ulcerative Colitis Treated With Tofacitinib
  Shruti Verma, Arshdeep Singh, Chandan Kakkar, Ashish Tripathi, Vandana Midha, Ajit Sood
  ACG Case Reports Journal.2023; 10(6): e01066.     CrossRef
• Intestinal tuberculosis can masquerade as Crohn’s disease: A teachable moment
  Pooja KC, Madhur Bhattarai, Subodh Adhikari, Prakriti Parajuli, Sujata Bhandari, Himal Bikram Bhattarai, Niraj Kumar Sharma, Shailendra Karki, Suryakiran Acharya, Bibhusan Basnet
  SAGE Open Medical Case Reports.2023;[Epub]     CrossRef
• The safety of vedolizumab in a patient with Crohn’s disease who developed anti-TNF-alpha agent associated latent tuberculosis infection reactivation: A case report
  Yuya Sugiyama, Nobuhiro Ueno, Shion Tachibana, Yu Kobayashi, Yuki Murakami, Takahiro Sasaki, Aki Sakatani, Keitaro Takahashi, Katsuyoshi Ando, Shin Kashima, Kentaro Moriichi, Hiroki Tanabe, Toshikatsu Okumura, Mikihiro Fujiya
  Medicine.2023; 102(28): e34331.     CrossRef
• Tofacitinib in Steroid-Refractory Acute Severe Ulcerative Colitis: A Retrospective Analysis
  Sayan Malakar, Srikanth Kothalkar, Umair Shamsul Hoda, Uday C Ghoshal
  Cureus.2023;[Epub]     CrossRef
• Crohn’s disease and intestinal tuberculosis: challenging from every angle
  Andreia Guimarães, João Gama, Luis Curvo-Semedo, António Canaveira Manso
  BMJ Case Reports.2023; 16(12): e254400.     CrossRef
• Development of Spinal Tuberculosis in an Adolescent With Crohn's Disease After Infliximab Therapy: A Case Report With Literature Review
  Jae Hoon Jung, Sujin Choi, Youra Kang, Dae-Chul Cho, So Mi Lee, Tae In Park, Byung-Ho Choe, Dongsub Kim, Ben Kang
  Frontiers in Pediatrics.2022;[Epub]     CrossRef
• Increased Risk of Infection With High Infliximab Trough Level
  Suprabhat Giri, Harish Darak
  Journal of Clinical Gastroenterology.2022; 56(4): 374.     CrossRef
• Impact of Immunosuppressive Therapy on the Performance of Latent Tuberculosis Screening Tests in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
  Chan Hyuk Park, Jung Ho Park, Yoon Suk Jung
  Journal of Personalized Medicine.2022; 12(3): 507.     CrossRef
• Evidence-Based Commentary: Testing and Treating Latent Tuberculosis Before Starting Biologics and Small Molecules in Patients with Inflammatory Bowel Disease
  Rinkalben Kakadiya, Vishal Sharma
  Journal of Gastrointestinal Infections.2022; 12(02): 128.     CrossRef
• Frequency of Positive Conversion of Interferon-Gamma Release Assay Results Among Patients With Inflammatory Bowel Disease Treated With Non-tumor Necrosis Factor Inhibitors
  Kyuwon Kim, Kyung-Wook Jo, Tae Sun Shim, Jin Hwa Park, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
  Frontiers in Medicine.2021;[Epub]     CrossRef
• Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab
  Sujin Choi, Bong Seok Choi, Byung-Ho Choe, Ben Kang
  Yeungnam University Journal of Medicine.2021; 38(3): 251.     CrossRef
• Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study
  Haruhiko Ogata, Takashi Hagiwara, Takeshi Kawaberi, Mariko Kobayashi, Toshifumi Hibi
  Intestinal Research.2021; 19(4): 419.     CrossRef
• Targeted versus universal tuberculosis chemoprophylaxis in 1968 patients with inflammatory bowel disease receiving anti‐TNF therapy in a tuberculosis endemic region
  Lingna Ye, Thomas P. Chapman, Zhenzhen Wen, Lang Lin, Yun Qiu, Zhanju Liu, Zhihua Ran, Jiaming Qian, Kaichun Wu, Xiang Gao, Pinjin Hu, Minhu Chen, Simon P. L. Travis, Qian Cao
  Alimentary Pharmacology & Therapeutics.2021; 53(3): 390.     CrossRef
• Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries
  Rupa Banerjee, Raja Affendi Raja Ali, Shu Chen Wei, Shashi Adsul
  Gut and Liver.2020; 14(6): 685.     CrossRef
• Increased Risk of Herpes Zoster in Young and Metabolically Healthy Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study
  Hosim Soh, Jaeyoung Chun, Kyungdo Han, Seona Park, Gukhwan Choi, Jihye Kim, Jooyoung Lee, Jong Pil Im, Joo Sung Kim
  Gut and Liver.2019; 13(3): 333.     CrossRef
• Screening for latent tuberculosis in patients with inflammatory bowel disease under antitumor necrosis factor: data from a Portuguese center
  Mafalda Sousa, Inês Ladeira, Ana Ponte, Carlos Fernandes, Adélia Rodrigues, Ana P. Silva, João Silva, Catarina Gomes, Edgar Afeto, João Carvalho
  European Journal of Gastroenterology & Hepatology.2019; 31(9): 1099.     CrossRef
• The Use of Biologics and Biosimilar in Asian patients with IBD: Are we ready?
  Joyce WY Mak, Joseph JY Sung
  Journal of Gastroenterology and Hepatology.2019; 34(8): 1269.     CrossRef
• Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease
  Youn I Choi, Tae Jun Kim, Dong Kyun Park, Jun-won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim
  International Journal of Colorectal Disease.2019; 34(10): 1713.     CrossRef
• Multidrug-resistant Disseminated Tuberculosis Related to Infliximab in a Patient with Ulcerative Colitis and Negative Evaluation for Latent Tuberculosis
  Yu Kyung Jun, Jaeyoung Chun, Eun Ae Kang, Hyun Jung Lee, Jong Pil Im, Joo Sung Kim
  The Korean Journal of Gastroenterology.2019; 74(3): 168.     CrossRef
• Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication)
  
  Intestinal Research.2018; 16(2): 178.     CrossRef
• High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India
  Ashish Agarwal, Saurabh Kedia, Saransh Jain, Vipin Gupta, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Venigalla Pratap Mouli, Rajan Dhingra, Govind Makharia, Vineet Ahuja
  Intestinal Research.2018; 16(4): 588.     CrossRef
• Risk of infection associated with anti-TNF-α therapy
  Mario Fernández-Ruiz, José María Aguado
  Expert Review of Anti-infective Therapy.2018; 16(12): 939.     CrossRef

Because anti-tumor necrosis factor (anti-TNF) therapy has become increasingly popular in many Asian countries, the risk of developing active tuberculosis (TB) among anti-TNF users may raise serious health problems in this region. Thus, the Asian Organization for Crohn's and Colitis and the Asia Pacific Association of Gastroenterology have developed a set of consensus statements about risk assessment, detection and prevention of latent TB infection, and management of active TB infection in patients with inflammatory bowel disease (IBD) receiving anti-TNF treatment. Twenty-three consensus statements were initially drafted and then discussed by the committee members. The quality of evidence and the strength of recommendations were assessed by using the Grading of Recommendations Assessment, Development, and Evaluation methodology. Web-based consensus voting was performed by 211 IBD specialists from 9 Asian countries concerning each statement. A consensus statement was accepted if at least 75% of the participants agreed. Part 2 of the statements comprised 3 parts: management of latent TB in preparation for anti-TNF therapy, monitoring during anti-TNF therapy, and management of an active TB infection after anti-TNF therapy. These consensus statements will help clinicians optimize patient outcomes by reducing the morbidity and mortality related to TB infections in patients with IBD receiving anti-TNF treatment.

Citations

Citations to this article as recorded by  

• Risk of Tuberculosis and Hepatitis B Reactivation in Patients With Crohn’s Disease on Ustekinumab: A Nationwide Real-World Study
  Rongbei Liu, Zhilun Li, Lingna Ye, Jing Hu, Jian Tang, Baili Chen, Xiuli Chen, Bei Tan, Yubei Gu, Chen Xie, Chunhui Ouyang, Xiaomei Song, Fan Li, Yanyun Fan, Haixia Ren, Liangru Zhu, Min Chen, Wenyu Jiang, Qian Cao
  Inflammatory Bowel Diseases.2024; 30(1): 45.     CrossRef
• Medical management of pediatric inflammatory bowel disease in the Asia‐Pacific region: A position paper by the Asian Pan‐Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group
  Way Seah Lee, Katsuhiro Arai, George Alex, Suporn Treepongkaruna, Kyung Mo Kim, Chee Liang Choong, Karen S. C. Mercado, Andy Darma, Anshu Srivastava, Marion M. Aw
  Journal of Gastroenterology and Hepatology.2023; 38(4): 523.     CrossRef
• Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
  Soo-Young Na, Chang Hwan Choi, Eun Mi Song, Ki Bae Bang, Sang Hyoung Park, Eun Soo Kim, Jae Jun Park, Bora Keum, Chang Kyun Lee, Bo-In Lee, Seung-Bum Ryoo, Seong-Joon Koh, Miyoung Choi, Joo Sung Kim
  Intestinal Research.2023; 21(1): 61.     CrossRef
• Miliary Tuberculosis in a Patient With Ulcerative Colitis Treated With Tofacitinib
  Shruti Verma, Arshdeep Singh, Chandan Kakkar, Ashish Tripathi, Vandana Midha, Ajit Sood
  ACG Case Reports Journal.2023; 10(6): e01066.     CrossRef
• IBD barriers across the continents – East Asia
  Joyce Wing Yan Mak, Agnes Hiu Yan Ho, Siew Chien Ng
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Development of Spinal Tuberculosis in an Adolescent With Crohn's Disease After Infliximab Therapy: A Case Report With Literature Review
  Jae Hoon Jung, Sujin Choi, Youra Kang, Dae-Chul Cho, So Mi Lee, Tae In Park, Byung-Ho Choe, Dongsub Kim, Ben Kang
  Frontiers in Pediatrics.2022;[Epub]     CrossRef
• A case of paradoxical response during anti-tuberculosis treatment in a patient with ulcerative colitis
  Shuhei Hosomi, Naoko Sugita, Atsushi Kanamori, Masaki Ominami, Koji Otani, Noriko Kamata, Fumio Tanaka, Yasuaki Nagami, Koichi Taira, Yasuhiro Fujiwara
  Clinical Journal of Gastroenterology.2022; 15(3): 592.     CrossRef
• Prophylactic Antitubercular Therapy Is Associated With Accelerated Disease Progression in Patients With Crohn's Disease Receiving Anti-TNF Therapy: A Retrospective Multicenter Study
  Fen Liu, Jian Tang, Lingna Ye, Jinyu Tan, Yun Qiu, Fan Hu, Jinshen He, Baili Chen, Yao He, Zhirong Zeng, Ren Mao, Qian Cao, Xiang Gao, Minhu Chen
  Clinical and Translational Gastroenterology.2022; 13(6): e00493.     CrossRef
• Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab
  Sujin Choi, Bong Seok Choi, Byung-Ho Choe, Ben Kang
  Yeungnam University Journal of Medicine.2021; 38(3): 251.     CrossRef
• Current status of inflammatory bowel diseases in Korea
  Suk-Kyun Yang
  Journal of the Korean Medical Association.2021; 64(9): 572.     CrossRef
• Anti-tumor Necrosis Factor Agents and Tuberculosis in Inflammatory Bowel Disease
  Yunho Jung
  The Korean Journal of Gastroenterology.2020; 75(1): 1.     CrossRef
• Clinical Features and Outcomes of Tuberculosis in Inflammatory Bowel Disease Patients Treated with Anti-tumor Necrosis Factor Therapy
  Jihye Kim, Jong Pil Im, Jae-Joon Yim, Chang Kyun Lee, Dong Il Park, Chang Soo Eun, Sung-Ae Jung, Jeong Eun Shin, Kang-Moon Lee, Jae Hee Cheon
  The Korean Journal of Gastroenterology.2020; 75(1): 29.     CrossRef
• Preoperative hypoalbuminemia is an independent risk factor for postoperative complications in Crohn's disease patients with normal BMI: A cohort study
  Xiaolong Ge, Huaying Liu, Shasha Tang, Yan Wu, Yipeng Pan, Wei Liu, Weilin Qi, Lingna Ye, Qian Cao, Wei Zhou
  International Journal of Surgery.2020; 79: 294.     CrossRef
• Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries
  Rupa Banerjee, Raja Affendi Raja Ali, Shu Chen Wei, Shashi Adsul
  Gut and Liver.2020; 14(6): 685.     CrossRef
• Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease
  Youn I Choi, Tae Jun Kim, Dong Kyun Park, Jun-won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim
  International Journal of Colorectal Disease.2019; 34(10): 1713.     CrossRef
• Translating the gut microbiome: ready for the clinic?
  Susan V. Lynch, Siew C. Ng, Fergus Shanahan, Herbert Tilg
  Nature Reviews Gastroenterology & Hepatology.2019; 16(11): 656.     CrossRef
• Multidrug-resistant Disseminated Tuberculosis Related to Infliximab in a Patient with Ulcerative Colitis and Negative Evaluation for Latent Tuberculosis
  Yu Kyung Jun, Jaeyoung Chun, Eun Ae Kang, Hyun Jung Lee, Jong Pil Im, Joo Sung Kim
  The Korean Journal of Gastroenterology.2019; 74(3): 168.     CrossRef
• Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication)
  
  Intestinal Research.2018; 16(2): 178.     CrossRef
• A rare case of disseminated histoplasmosis in a patient with Crohn’s disease on immunosuppressive treatment
  Bhavesh Bhut, Akshay Kulkarni, Varnika Rai, Vinita Agrawal, Abhai Verma, Manoj Jain, Rungmei S K Marak, Ajai Kumar Dixit, Uday C Ghoshal
  Indian Journal of Gastroenterology.2018; 37(5): 472.     CrossRef
• High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India
  Ashish Agarwal, Saurabh Kedia, Saransh Jain, Vipin Gupta, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Venigalla Pratap Mouli, Rajan Dhingra, Govind Makharia, Vineet Ahuja
  Intestinal Research.2018; 16(4): 588.     CrossRef

Citations

Citations to this article as recorded by  

• When should patients take simethicone orally before colonoscopy for avoiding bubbles: A single-blind, randomized controlled study
  Woohyuk Jung, Gyu Man Oh, Jae Hyun Kim, Youn Jung Choi, Min Young Son, Kyoungwon Jung, Sung Eun Kim, Won Moon, Moo In Park, Seun Ja Park
  Medicine.2023; 102(19): e33728.     CrossRef
• Comparison of the efficacy and safety between oral sulfate tablet and polyethylene glycol for bowel preparation before colonoscopy according to age
  Jae Hyun Kim, Yong Eun Park, Tae Oh Kim, Jongha Park, Gyu Man Oh, Won Moon, Seun Ja Park
  Medicine.2022; 101(27): e29884.     CrossRef
• Optimization of the surveillance strategy in patients with colorectal adenomas: A combination of clinical parameters and index colonoscopy findings
  Chan Hyuk Park, Yoon Suk Jung, Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn
  Journal of Gastroenterology and Hepatology.2021; 36(4): 974.     CrossRef
• Postgastrectomy gastric cancer patients are at high risk for colorectal neoplasia: a case control study
  Tae-Geun Gweon, Kyu-Tae Yoon, Chang Hyun Kim, Jin-Jo Kim
  Intestinal Research.2021; 19(2): 239.     CrossRef
• Risk of developing metachronous advanced colorectal neoplasia after resection of low-risk diminutive versus small adenomas
  Nam Hee Kim, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Chong Il Sohn
  Gastrointestinal Endoscopy.2020; 91(3): 622.     CrossRef
• Optimal Colonoscopic Surveillance Interval After Normal Baseline Screening Colonoscopy
  Jian Dong, Minman Wu, Jiarong Miao, Rana Sami Ullah Khan, Tao Zhi, Tianmei Zhang, Xue Li, Yashi Peng, Gang Yang, Qiong Nan
  Gastroenterology Nursing.2020; 43(3): 225.     CrossRef
• Comparative systematic review and meta-analysis of 1- to 5-mm versus 6- to 9-mm adenomas on the risk of metachronous advanced colorectal neoplasia
  Yoon Suk Jung, Tae Jun Kim, Eunwoo Nam, Chan Hyuk Park
  Gastrointestinal Endoscopy.2020; 92(3): 692.     CrossRef
• Appropriate Surveillance Interval after Colonoscopic Polypectomy in Patients Younger than 50 Years
  Yoon Suk Jung, Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn
  Journal of Korean Medical Science.2019;[Epub]     CrossRef
• Impact of obesity and metabolic abnormalities on the risk of metachronous colorectal neoplasia after polypectomy in men
  Nam Hee Kim, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Chong Il Sohn
  Journal of Gastroenterology and Hepatology.2019; 34(9): 1504.     CrossRef
• What Is Appropriate Upper Endoscopic Interval Among Dyspeptic Patients With Previously Normal Endoscopy? A Multicenter Study With Bayesian Change Point Analysis
  Jong Wook Kim, Kee Wook Jung, Joong Goo Kwon, Jung Bok Lee, Jong Kyu Park, Ki Bae Bang, Chung Hyun Tae, Jung Hwan Oh
  Journal of Neurogastroenterology and Motility.2019; 25(4): 544.     CrossRef
• Risk of Developing Metachronous Advanced Colorectal Neoplasia After Polypectomy in Patients With Multiple Diminutive or Small Adenomas
  Nam Hee Kim, Yoon Suk Jung, Mi Yeon Lee, Jung Ho Park, Dong Il Park, Chong Il Sohn
  American Journal of Gastroenterology.2019; 114(10): 1657.     CrossRef

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by a relapsing and remitting course. The direct and indirect costs of the treatment of UC are high, and the quality of life of patients is reduced, especially during exacerbation of the disease. The incidence and prevalence of UC in Korea are still lower than those of Western countries, but have been rapidly increasing during the past decades. Various medical and surgical therapies, including biologics, are currently used for the management of UC. However, many challenging issues exist, which sometimes lead to differences in practice between clinicians. Therefore, the IBD study group of the Korean Association for the Study of Intestinal Diseases established the first Korean guidelines for the management of UC in 2012. This is an update of the first guidelines. It was generally made by the adaptation of several foreign guidelines as was the first edition, and encompasses treatment of active colitis, maintenance of remission, and indication of surgery for UC. The specific recommendations are presented with the quality of evidence and classification of recommendations.

Citations

Citations to this article as recorded by  

• The impact of gut microbiome enterotypes on ulcerative colitis: identifying key bacterial species and revealing species co-occurrence networks using machine learning
  Xuangao Wu, Ting Zhang, TianShun Zhang, Sunmin Park
  Gut Microbes.2024;[Epub]     CrossRef
• Complementary Therapeutic Effect of Fecal Microbiota Transplantation in Ulcerative Colitis after the Response to Anti-Tumor Necrosis Factor Alpha Agent Was Lost: A Case Report
  Jongbeom Shin, Ga Hyeon Baek, Boram Cha, Soo-Hyun Park, Jung-Hwan Lee, Jun-Seob Kim, Kye Sook Kwon
  Biomedicines.2024; 12(4): 800.     CrossRef
• Anti‐inflammatory and anti‐hyperalgesic effects induced by an aqueous aged black garlic extract in rodent models of ulcerative colitis and colitis‐associated visceral pain
  Maria Loreta Libero, Elena Lucarini, Lucia Recinella, Clara Ciampi, Serena Veschi, Anna Piro, Annalisa Chiavaroli, Alessandra Acquaviva, Nilofar Nilofar, Giustino Orlando, Daniele Generali, Carla Ghelardini, Lorenzo di Cesare Mannelli, Antonio J. Montero‐
  Phytotherapy Research.2024; 38(8): 4177.     CrossRef
• Risks of Cancer Associated with Therapeutic Drugs for Inflammatory Bowel Disease
  Won Moon, Jae Jun Park
  The Korean Journal of Gastroenterology.2024; 83(6): 233.     CrossRef
• Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti-Tumor Necrosis Factors
  Sang Un Kim, Hyun Seok Lee
  The Korean Journal of Gastroenterology.2024; 84(2): 35.     CrossRef
• Inflammatory Bowel Disease: Pathophysiology, Treatment, and Disease Modeling
  Jiryeon Jang, Sehoon Jeong
  BioChip Journal.2023; 17(4): 403.     CrossRef
• Factors associated with the prescription of probiotics in patients with inflammatory bowel disease: a cross-sectional study
  Joo Kyung Kim, Jae Hee Cheon
  Journal of Yeungnam Medical Science.2023; 40(1): 37.     CrossRef
• Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
  Soo-Young Na, Chang Hwan Choi, Eun Mi Song, Ki Bae Bang, Sang Hyoung Park, Eun Soo Kim, Jae Jun Park, Bora Keum, Chang Kyun Lee, Bo-In Lee, Seung-Bum Ryoo, Seong-Joon Koh, Miyoung Choi, Joo Sung Kim
  Intestinal Research.2023; 21(1): 61.     CrossRef
• Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: a KASID multicenter cohort study
  Seung Hwan Shin, Kyunghwan Oh, Sung Noh Hong, Jungbok Lee, Shin Ju Oh, Eun Soo Kim, Soo-Young Na, Sang-Bum Kang, Seong-Joon Koh, Ki Bae Bang, Sung-Ae Jung, Sung Hoon Jung, Kyeong Ok Kim, Sang Hyoung Park, Suk-Kyun Yang, Chang Hwan Choi, Byong Duk Ye
  Therapeutic Advances in Gastroenterology.2023; 16: 175628482311541.     CrossRef
• Low Serum Hepcidin Levels in Patients with Ulcerative Colitis – Implications for Treatment of Co-existent Iron-Deficiency Anemia
  Jagadish Ramasamy, Chinmai Jagadish, Abitha Sukumaran, Joe Varghese, Thenmozhi Mani, A. J. Joseph, Ebby George Simon, Molly Jacob
  Inflammation.2023; 46(6): 2209.     CrossRef
• Screening for Chemical Characterization and Pharmacological Properties of Different Extracts from Nepeta italica
  Alessandra Acquaviva, Simonetta Cristina Di Simone, Nilofar, Abdelhakim Bouyahya, Gokhan Zengin, Lucia Recinella, Sheila Leone, Luigi Brunetti, Abdullahi Ibrahim Uba, Osman Guler, Maruf Balos, Ugur Cakilcioğlu, Luigi Menghini, Claudio Ferrante, Giustino
  Plants.2023; 12(15): 2785.     CrossRef
• Treatment of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
  Eun Mi Song, Soo-Young Na, Sung Noh Hong, Siew Chien Ng, Tadakazu Hisamatsu, Byong Duk Ye
  Intestinal Research.2023; 21(3): 339.     CrossRef
• Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
  Yu Kyung Jun, Seong-Joon Koh, Dae Seong Myung, Sang Hyoung Park, Choon Jin Ooi, Ajit Sood, Jong Pil Im
  Intestinal Research.2023; 21(3): 353.     CrossRef
• Advancements in the Management of Moderate-to-Severe Ulcerative Colitis: A Revised 2023 Korean Treatment Guidelines
  Soo-Young Na
  The Korean Journal of Medicine.2023; 98(5): 223.     CrossRef
• Comparison of 1-Year Colectomy Risk Between the US and Korean Patients with Acute Severe Ulcerative Colitis: A Propensity Score Matching Analysis
  Eun Soo Kim, Kyeong Ok Kim, Byung Ik Jang, Eun Young Kim, Yoo Jin Lee, Hyun Seok Lee, Joon Seop Lee, Sung Kook Kim, Yun Jin Jung, Sang-Bum Kang, Manasi Agrawal, Ryan Ungaro, Jean-Frederic Colombel
  Digestive Diseases and Sciences.2022; 67(7): 2866.     CrossRef
• Cytomegalovirus in ulcerative colitis: an evidence-based approach to diagnosis and treatment
  Anuraag Jena, Shubhra Mishra, Anupam Kumar Singh, Aravind Sekar, Vishal Sharma
  Expert Review of Gastroenterology & Hepatology.2022; 16(2): 109.     CrossRef
• Efficacy of sigmoidoscopy for evaluating disease activity in patients with ulcerative colitis
  Su Bum Park, Seong-Jung Kim, Jun Lee, Yoo Jin Lee, Dong Hoon Baek, Geom Seog Seo, Eun Soo Kim, Sang-Wook Kim, So Yeong Kim
  BMC Gastroenterology.2022;[Epub]     CrossRef
• Identification of useful genes from multiple microarrays for ulcerative colitis diagnosis based on machine learning methods
  Lin Zhang, Rui Mao, Chung Tai Lau, Wai Chak Chung, Jacky C. P. Chan, Feng Liang, Chenchen Zhao, Xuan Zhang, Zhaoxiang Bian
  Scientific Reports.2022;[Epub]     CrossRef
• Oral beclomethasone dipropionate as an add-on therapy and response prediction in Korean patients with ulcerative colitis
  Kyuwon Kim, Hee Seung Hong, Kyunghwan Oh, Jae Yong Lee, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye, Sang Hyoung Park
  The Korean Journal of Internal Medicine.2022; 37(6): 1140.     CrossRef
• Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis
  Soo-Kyung Park, Sang-Bum Kang, SangSoo Kim, Tae Oh Kim, Jae Myung Cha, Jong Pil Im, Chang Hwan Choi, Eun Soo Kim, Geom Seog Seo, Chang Soo Eun, Dong Soo Han, Dong Il Park
  The Korean Journal of Internal Medicine.2022; 37(5): 949.     CrossRef
• Physician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION study
  Yehyun Park, Chang Hwan Choi, Hyun Soo Kim, Hee Seok Moon, Do Hyun Kim, Jin Ju Kim, Dennis Teng, Dong Il Park
  Intestinal Research.2022; 20(4): 452.     CrossRef
• Corticosteroid, a double-edged sword in inflammatory bowel disease management: possibility of reducing corticosteroid use through physician education
  Seulji Kim, Seong-Joon Koh
  Intestinal Research.2022; 20(4): 389.     CrossRef
• La escala control nutricional (CONUT): una herramienta prometedora para el cribado nutricional y como predictor de severidad en la colitis ulcerosa crónica idiopática
  J.L. de-León-Rendón, R.Y. López-Pérez, N.I. Gracida-Mancilla, B. Jiménez-Bobadilla, L. Alarcón-Bernés, S. Mendoza-Ramírez, J.A. Villanueva-Herrero
  Revista de Gastroenterología de México.2021; 86(2): 110.     CrossRef
• Advances in Management of Intestinal Behçet’s Disease: A Perspective From Gastroenterologists
  Jae Hee Cheon
  Journal of Rheumatic Diseases.2021; 28(1): 4.     CrossRef
• Tumor Necrosis Factor-Alpha Inhibitor-Associated Psoriatic Alopecia in a Patient with Ulcerative Colitis: A Case Report and Review of the Literature
  Kyung Muk Jeong, Ji Yun Seo, Anna Kim, Yoo Sang Baek, Hae Jun Song, Jiehyun Jeon
  Annals of Dermatology.2021; 33(1): 82.     CrossRef
• The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis
  Yujin Jeong, Seong Ran Jeon, Hyun Gun Kim, Jung Rock Moon, Tae Hee Lee, Jae Young Jang, Jun-Hyung Cho, Jun Seok Park, Heesu Park, Ki-hun Lee, Jin-Oh Kim, Joon Seong Lee, Bong Min Ko, Suyeon Park
  Intestinal Research.2021; 19(1): 62.     CrossRef
• Comparative Study of Anti-Inflammatory Effect on DSS-Induced Ulcerative Colitis Between Novel Glycyrrhiza Variety and Official Compendia
  Sa-Haeng Kang, Young-Jae Song, Yong-Deok Jeon, Dong-Keun Kim, Jeong-Hyang Park, Ju-Ryoun Soh, Jong-Hyun Lee, Christopher Kitalong, Wonnam Kim, Hyo-Jin An, Jae-Ki Chang, Jeonghoon Lee, Jong-Sik Jin
  Applied Sciences.2021; 11(4): 1545.     CrossRef
• McN-A-343, a muscarinic agonist, reduces inflammation and oxidative stress in an experimental model of ulcerative colitis
  Diva de Aguiar Magalhães, Jalles Arruda Batista, Stefany Guimarães Sousa, Jayro dos Santos Ferreira, Lauanda da Rocha Rodrigues, Cynthia Maria Carvalho Pereira, José Victor do Nascimento Lima, Ieda Figueira de Albuquerque, Nayonara Lanara Sousa Dutra Beze
  Life Sciences.2021; 272: 119194.     CrossRef
• Comparison of Long-Term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naïve Patients with Ulcerative Colitis
  Yong Il Lee, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim, Jae Hee Cheon
  Gut and Liver.2021; 15(2): 232.     CrossRef
• The controlling nutritional status score: A promising tool for nutritional screening and predicting severity in ulcerative colitis patients
  J.L. de-León-Rendón, R.Y. López-Pérez, N.I. Gracida-Mancilla, B. Jiménez-Bobadilla, L. Alarcón-Bernés, S. Mendoza-Ramírez, J.A. Villanueva-Herrero
  Revista de Gastroenterología de México (English Edition).2021; 86(2): 110.     CrossRef
• Comparison of outcomes of cyclosporine A and infliximab for steroid‐refractory acute severe ulcerative colitis
  Eun Mi Song, Eun Hye Oh, Sung Wook Hwang, Sang Hyoung Park, Dong‐Hoon Yang, Jeong‐Sik Byeon, Seung‐Jae Myung, Suk‐Kyun Yang, Byong Duk Ye
  Journal of Gastroenterology and Hepatology.2021; 36(9): 2463.     CrossRef
• Clinical Significance of Residual Nonrectal Inflammation in Ulcerative Colitis Patients in Clinical Remission
  Jongbeom Shin, Sung Min Kong, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Young-Ho Kim
  Gut and Liver.2021; 15(3): 401.     CrossRef
• The real-world outcomes of vedolizumab in patients with ulcerative colitis in Korea: a multicenter retrospective study
  Byong Duk Ye, Jae Hee Cheon, Ki Hwan Song, Joo Sung Kim, Young-Ho Kim, Hyuk Yoon, Kang-Moon Lee, Sang-Bum Kang, Byung Ik Jang, Jae Jun Park, Tae Oh Kim, Dae-Wook Lee, Chee Yoong Foo, Jeong Eun Shin, Dong Il Park
  Therapeutic Advances in Gastroenterology.2021; 14: 175628482110247.     CrossRef
• Efficacy and safety of Etiasa for treatment of mild-to-moderate ulcerative colitis: A Meta-analysis
  Fang-Mei Ling, Fei-Nan Lu, Sheng-Nan Wang, Liang-Ru Zhu
  World Chinese Journal of Digestology.2021; 29(15): 880.     CrossRef
• Draft Genome Sequence of Paraclostridium bifermentans subsp. muricolitidis Strain PAGU 1678 T , Which Exacerbates Pathosis in a Mouse Model of Ulcerative Colitis
  Ryo Kutsuna, Tohru Miyoshi-Akiyama, Junko Tomida, Yoshiaki Kawamura, Steven R. Gill
  Microbiology Resource Announcements.2021;[Epub]     CrossRef
• Treatment of inflammatory bowel diseases: focusing on 5-aminosalicylates and immunomodulators
  You Sun Kim
  Journal of the Korean Medical Association.2021; 64(9): 596.     CrossRef
• Is fasting beneficial for hospitalized patients with inflammatory bowel diseases?
  Yong Eun Park, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim, Jung Nam Kim, Na Rae Lee, Jae Hee Cheon
  Intestinal Research.2020; 18(1): 85.     CrossRef
• Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study
  Yoon Suk Jung, Minkyung Han, Sohee Park, Jae Hee Cheon
  Digestive Diseases and Sciences.2020; 65(5): 1436.     CrossRef
• Fecal calprotectin is more accurate than fecal immunochemical test for predicting mucosal healing in quiescent ulcerative colitis: a prospective multicenter study
  Eun Soo Kim, Hyun Seok Lee, Sung Kook Kim, Eun Young Kim, Byung Ik Jang, Kyeong Ok Kim, Chang Heon Yang, Yoo Jin Lee
  Scandinavian Journal of Gastroenterology.2020; 55(2): 163.     CrossRef
• Multidirectional Pharma-Toxicological Study on Harpagophytum procumbens DC. ex Meisn.: An IBD-Focused Investigation
  Lucia Recinella, Annalisa Chiavaroli, Maurizio Ronci, Luigi Menghini, Luigi Brunetti, Sheila Leone, Bruno Tirillini, Paola Angelini, Stefano Covino, Roberto Venanzoni, Gokhan Zengin, Simonetta Di Simone, Maria Chiara Ciferri, Viviana di Giacomo, Amelia Ca
  Antioxidants.2020; 9(2): 168.     CrossRef
• Pregnancy outcomes in women with inflammatory bowel disease: a 10‐year nationwide population‐based cohort study
  Han H. Lee, Jung Min Bae, Bo‐In Lee, Kang‐Moon Lee, Jeong H. Wie, Jin S. Kim, Young‐Seok Cho, Sung‐Ae Jung, Sang W. Kim, Hwang Choi, Myung‐Gyu Choi
  Alimentary Pharmacology & Therapeutics.2020; 51(9): 861.     CrossRef
• Effect of Age on the Initiation of Biologic Agent Therapy in Patients With Inflammatory Bowel Disease: Korean Common Data Model Cohort Study
  Youn I Choi, Yoon Jae Kim, Jun-Won Chung, Kyoung Oh Kim, Hakki Kim, Rae Woong Park, Dong Kyun Park
  JMIR Medical Informatics.2020; 8(4): e15124.     CrossRef
• Mechanism-based Drug Therapy of Inflammatory Bowel Disease With Special Reference to Rheumatic Disease
  Jae Jun Park
  Journal of Rheumatic Diseases.2020; 27(3): 128.     CrossRef
• Sarcopenia Is a New Risk Factor of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease
  Min Kyu Kang, Kyeong Ok Kim, Min Cheol Kim, Jung Gil Park, Byung Ik Jang
  Digestive Diseases.2020; 38(6): 507.     CrossRef
• Regional variations in the use of biologics and immunomodulators among Korean patients with inflammatory bowel diseases
  Minkyung Han, Yoon Suk Jung, Jae Hee Cheon, Sohee Park
  Journal of Gastroenterology and Hepatology.2019; 34(7): 1166.     CrossRef
• Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study
  Soo-Kyung Park, Sang Hyun Park, Chang Soo Eun, Geom Seog Seo, Jong Pil Im, Tae Oh Kim, Dong-Il Park
  Intestinal Research.2019; 17(3): 349.     CrossRef
• Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha use
  Ho Suk Kang, Ja-Seol Koo, Kang Moon Lee, Dae-Bum Kim, Ji Min Lee, Yoon Jae Kim, Hyuk Yoon, Hyun Joo Jang
  World Journal of Gastroenterology.2019; 25(8): 989.     CrossRef
• A Real-World Analysis of Prescribing Patterns and Non-persistence of Anti-TNFα Therapy for Inflammatory Bowel Disease
  Eun Jin Jang, Jung Eun Ha, Seul Gi Im, Myeong Gyu Kim, Hyun Soon Sohn
  Clinical Drug Investigation.2019; 39(7): 625.     CrossRef
• Medication Use and Drug Expenditure in Inflammatory Bowel Disease: based on Korean National Health Insurance Claims Data (2010-2014)
  Jung Eun Ha, Eun Jin Jang, Seul Gi Im, Hyun Soon Sohn
  Korean Journal of Clinical Pharmacy.2019; 29(2): 79.     CrossRef
• Protective effects induced by alcoholic Phlomis fruticosa and Phlomis herba‐venti extracts in isolated rat colon: Focus on antioxidant, anti‐inflammatory, and antimicrobial activities in vitro
  Claudio Ferrante, Lucia Recinella, Maurizio Ronci, Giustino Orlando, Simonetta Di Simone, Luigi Brunetti, Annalisa Chiavaroli, Sheila Leone, Matteo Politi, Bruno Tirillini, Paola Angelini, Stefano Covino, Roberto Venanzoni, Sanda Vladimir‐Knežević, Luigi
  Phytotherapy Research.2019; 33(9): 2387.     CrossRef
• Current Evidence for the Management of Inflammatory Bowel Diseases Using Fecal Microbiota Transplantation
  Seong Ran Jeon, Jocelyn Chai, Christiana Kim, Christine H. Lee
  Current Infectious Disease Reports.2018;[Epub]     CrossRef
• Monitoring Disease Activity: How and When?
  Kang-Moon Lee
  The Korean Journal of Gastroenterology.2018; 71(2): 69.     CrossRef
• Novel treatments for inflammatory bowel disease
  Hyo Sun Lee, Soo-Kyung Park, Dong Il Park
  The Korean Journal of Internal Medicine.2018; 33(1): 20.     CrossRef
• How to Optimally Use Currently Available Drugs in a Therapeutic Algorithm?
  You Sun Kim
  The Korean Journal of Gastroenterology.2018; 71(2): 74.     CrossRef
• Endoscopic Transplantation of Mesenchymal Stem Cell Sheets in Experimental Colitis in Rats
  Sehyung Pak, Sung Wook Hwang, In Kyong Shim, Sang Mun Bae, Yeon- Mi Ryu, Han-Byul Kim, Eun-ju Do, Hye-Nam Son, Eun-ji Choi, Sun-ha Park, Sang-Yeob Kim, Sang Hyoung Park, Byong Duk Ye, Suk-Kyun Yang, Nobuo Kanai, Masanori Maeda, Teruo Okano, Dong-Hoon Yang
  Scientific Reports.2018;[Epub]     CrossRef
• Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis?
  Seong Ran Jeon
  Intestinal Research.2018; 16(2): 163.     CrossRef
• Is Clostridium difficile infection a real threat in patients with ulcerative colitis? A prospective, multicenter study in Korea
  Dae Bum Kim, Kang-Moon Lee, Sang Hyoung Park, You Sun Kim, Eun Soo Kim, Jun Lee, Sung-Ae Jung, Geom Seog Seo, Ji Min Lee
  Intestinal Research.2018; 16(2): 267.     CrossRef
• Mesenchymal Stromal Cells in the Treatment of Perianal Fistulas in Crohn'S Disease
  Jesús Castro-Poceiro, Agnès Fernández-Clotet, Julián Panés
  Immunotherapy.2018; 10(14): 1203.     CrossRef
• Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia: A Randomized, Controlled Trial
  Hyuk Yoon, Dong Ho Lee, Yong-Hyun Lee, Ju-Cheol Jeong, Soo Teik Lee, Myung-Gyu Choi, Seong Woo Jeon, Ki-Nam Shim, Gwang Ho Baik, Jae Gyu Kim, Jeong Seop Moon, In-Kyung Sung, Sang Kil Lee, Poong-Lyul Rhee, Hwoon-Yong Jung, Bong Eun Lee, Hyun Soo Kim, Sang
  Gut and Liver.2018; 12(5): 516.     CrossRef
• Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
  Jihye Park, Jae Hee Cheon
  Intestinal Research.2017; 15(3): 263.     CrossRef
• Fatal infections in older patients with inflammatory bowel disease on anti-tumor necrosis factor therapy
  Way-Seah Lee, Najib Azmi, Ruey-Terng Ng, Sik-Yong Ong, Sasheela Sri La Ponnampalavanar, Sanjiv Mahadeva, Ida Hilmi
  Intestinal Research.2017; 15(4): 524.     CrossRef

Citations

Citations to this article as recorded by  

• Delays in definitive endoscopic resection of previously manipulated colorectal polyps as a risk factor for inferior resection outcomes
  Fares Ayoub, Grace E. Kim, Wenfei Wang, Dennis Chen, Uzma D. Siddiqui
  Gastrointestinal Endoscopy.2024; 100(1): 109.     CrossRef
• Is there a best choice of equipment for colorectal endoscopic submucosal dissection?
  Francesco Cocomazzi, Sonia Carparelli, Nunzia Labarile, Antonio Capogreco, Marco Gentile, Roberta Maselli, Jahnvi Dhar, Jayanta Samanta, Alessandro Repici, Cesare Hassan, Francesco Perri, Antonio Facciorusso
  Expert Review of Medical Devices.2024; 21(7): 561.     CrossRef
• Risk Factors for Post-Endoscopic Submucosal Dissection Electrocoagulation Syndrome in Patients with Colorectal Neoplasms: A Multicenter, Large-Scale, Retrospective Cohort Study by the Honam Association for the Study of Intestinal Disease (HASID)
  Hyo-Yeop Song, Seong-Jung Kim, Jun Lee, Byung Chul Jin, Dong Hyun Kim, Hyun-Soo Kim, Hyung-Hoon Oh, Young-Eun Joo, Dae-Seong Myung, Sang-Wook Kim, Geom-Seog Seo
  Journal of Clinical Medicine.2024; 13(13): 3932.     CrossRef
• Hybrid Versus Conventional Colorectal Endoscopic Submucosal Dissection: A Multicenter Randomized Controlled Trial (Short-Endoscopic Submucosal Dissection)
  Dennis Yang, Muhammad K. Hasan, Salmaan Jawaid, Gurdeep Singh, Yasi Xiao, Mai Khalaf, Yutaka Tomizawa, Neil S. Sharma, Peter V. Draganov, Mohamed O. Othman
  American Journal of Gastroenterology.2024;[Epub]     CrossRef
• The Derivation and External Validation of a Fibrosis Risk Model for Colorectal Tumours Undergoing Endoscopic Submucosal Dissection
  Sandro Sferrazza, Marcello Maida, Giulio Calabrese, Antonio Facciorusso, Lorenzo Fuccio, Leonardo Frazzoni, Roberta Maselli, Alessandro Repici, Roberto Di Mitri, João Santos-Antunes
  Journal of Clinical Medicine.2024; 13(15): 4517.     CrossRef
• Development and validation of a predictive model for submucosal fibrosis in patients with early gastric cancer undergoing endoscopic submucosal dissection: experience from a large tertiary center
  Yunqing Zeng, Jinhou Li, Yuan Zheng, Di Zhang, Ning Zhong, Xiuli Zuo, Yanqing Li, Wenbin Yu, Jiaoyang Lu
  Annals of Medicine.2024;[Epub]     CrossRef
• Comparing underwater endoscopic submucosal dissection and conventional endoscopic submucosal dissection for large laterally spreading tumor: a randomized controlled trial (with video)
  Chang Kyo Oh, Hwe Hoon Chung, Jae Keun Park, Jiyoon Jung, Hee Yeon Lee, Yu Jin Kim, Jin Bae Kim
  Gastrointestinal Endoscopy.2024;[Epub]     CrossRef
• Outcomes and Learning Curve in Endoscopic Submucosal Dissection of Rectal Neoplasms with Severe Fibrosis: Experience of a Western Center
  Catarina Félix, Pedro Barreiro, Rui Mendo, André Mascarenhas, Cristina Chagas
  GE - Portuguese Journal of Gastroenterology.2023; 30(3): 221.     CrossRef
• Endoscopic submucosal dissection for colorectal polyps: outcome determining factors
  Chi Woo Samuel Chow, Tak Lit Derek Fung, Pak Tat Chan, Kam Hung Kwok
  Surgical Endoscopy.2023; 37(2): 1293.     CrossRef
• Safety and feasibility of same-day discharge after endoscopic submucosal dissection: a Western multicenter prospective cohort study
  William King, Peter Draganov, V.Subhash Gorrepati, Maham Hayat, Hiroyuki Aihara, Michael Karasik, Saowanee Ngamruengphong, Abdul Aziz Aadam, Mohamed O. Othman, Neil Sharma, Ian S. Grimm, Alaa Rostom, B. Joseph Elmunzer, Dennis Yang
  Gastrointestinal Endoscopy.2023; 97(6): 1045.     CrossRef
• Is colorectal endoscopic submucosal dissection safe and effective for 15–19-mm tumors?
  Yunho Jung, Young Hwangbo, Young Sin Cho, Seong Woo Choi, Seong Ran Jeon, Hyun Gun Kim, Bong Min Ko, Jin-O Kim
  International Journal of Colorectal Disease.2023;[Epub]     CrossRef
• Initial multicenter experience using a novel articulating through-the-scope traction device for endoscopic submucosal dissection
  Maham Hayat, Alexander Schlachterman, Grace Schiavone, Meir Mizrahi, Jong Kyu Park, Vivek Kumbhari, Antonio Cheesman, Peter V Draganov, Muhammad Khalid Hasan, Dennis Yang
  Endoscopy International Open.2023; 11(08): E778.     CrossRef
• Novel beagle model of gastric local fibrotic target lesions for the evaluation and training of endoscopic techniques
  Xiao-Jian He, Xiao-Ling Wang, Chuan-Shen Jiang, Dong-Gui Hong, Hai-Lan Lin, Yun-Ping Zheng, Han Li, Xin-Jiang Chen, Jian-Xiao Huang, Ling-Shuang Dai, Mei-Yan Liu, Bao-Xiang Luo, Dong-Liang Li, Da-Zhou Li, Wen Wang
  BMC Gastroenterology.2023;[Epub]     CrossRef
• Comparison of precutting endoscopic mucosal resection and endoscopic submucosal dissection for large (20–30 mm) flat colorectal lesions
  Chang Kyo Oh, Young Wook Cho, In Hyoung Choi, Han Hee Lee, Chul‐Hyun Lim, Jin Su Kim, Bo‐In Lee, Young‐Seok Cho
  Journal of Gastroenterology and Hepatology.2022; 37(3): 568.     CrossRef
• Endoscopic Submucosal Dissection in North America: A Large Prospective Multicenter Study
  Peter V. Draganov, Hiroyuki Aihara, Michael S. Karasik, Saowanee Ngamruengphong, Abdul Aziz Aadam, Mohamed O. Othman, Neil Sharma, Ian S. Grimm, Alaa Rostom, B. Joseph Elmunzer, Salmaan A. Jawaid, Donevan Westerveld, Yaseen B. Perbtani, Brenda J. Hoffman,
  Gastroenterology.2021; 160(7): 2317.     CrossRef
• Pocket-creation method improves efficacy of colorectal endoscopic submucosal dissection: a system review and meta-analysis
  Jian Gong, Tong Chen, Yuyong Tan, Deliang Liu
  European Journal of Gastroenterology & Hepatology.2021; 33(10): 1241.     CrossRef
• Impact of Procedure Time of Preceding Endoscopic Submucosal Dissection on the Difficulty of Laparoscopic Rectal Surgery
  Hiroaki Nozawa, Kazushige Kawai, Kazuhito Sasaki, Shigenobu Emoto, Koji Murono, Hirofumi Sonoda, Hiroaki Ishii, Soichiro Ishihara
  International Surgery.2021; 105(1-3): 528.     CrossRef
• Factors Associated with Fibrosis during Colorectal Endoscopic Submucosal Dissection: Does Pretreatment Biopsy Potentially Elicit Submucosal Fibrosis and Affect Endoscopic Submucosal Dissection Outcomes?
  Masatake Kuroha, Hisashi Shiga, Yoshitake Kanazawa, Hiroshi Nagai, Tomoyuki Handa, Ryo Ichikawa, Motoyuki Onodera, Takeo Naito, Rintaro Moroi, Tomoya Kimura, Katsuya Endo, Yoichi Kakuta, Yoshitaka Kinouchi, Tooru Shimosegawa, Atsushi Masamune
  Digestion.2021; 102(4): 590.     CrossRef
• Endoscopic submucosal dissection in rectal tumors extending or not to the dentate line: A comparative analysis
  Déborah Roland, Gabriel Rahmi, Enrique Pérez-Cuadrado-Robles, Guillaume Perrod, Jérémie Jacques, Maximilien Barret, Sarah Leblanc, Arthur Berger, Jérémie Albouys, Stanislas Chaussade, Christophe Cellier
  Digestive and Liver Disease.2020; 52(3): 296.     CrossRef
• Novel approach to endoscopic submucosal dissection of a cecal lesion with nonlifting sign by submucosal fatty tissue with use of selective-regulation high-pressure water-jet method and immersion in saline solution
  Felipe Ramos-Zabala, Sabina Beg, Marian García-Mayor, Adolfo Parra-Blanco, Luis Moreno-Almazán
  VideoGIE.2020; 5(3): 116.     CrossRef
• Review on colorectal endoscopic submucosal dissection focusing on the technical aspect
  Tak Lit Derek Fung, Chi Woo Samuel Chow, Pak Tat Chan, Kam Hung Kwok
  Surgical Endoscopy.2020; 34(9): 3766.     CrossRef
• Endoscopic Biopsy in Differential Diagnosis of Colorectal Serrated Lesions
  K. D. Khalin, M. Yu. Agapov, L. V. Zvereva, K. V. Stegniy
  Russian Journal of Gastroenterology, Hepatology, Coloproctology.2020; 30(3): 42.     CrossRef
• Predictors for Submucosal Fibrosis in Patients With Superficial Squamous Esophageal Neoplasia Undergoing Endoscopic Submucosal Dissection
  Xiaoduan Zhuang, Ming Xu, Zhenyu Chen, Jianqi Wang, Kai Qian, Shihao Wang, Guoming Deng, Yang Bai
  Clinical and Translational Gastroenterology.2020; 11(8): e00188.     CrossRef
• Hybrid resection with ESD and FTRD: Could this be a rescue treatment in the presence of severe submucosal fibrosis?
  Gianluca Andrisani, Francesco Maria Di Matteo
  Digestive and Liver Disease.2019; 51(4): 607.     CrossRef
• Factors Predictive of Complete Excision of Large Colorectal Neoplasia Using Hybrid Endoscopic Submucosal Dissection: A KASID Multicenter Study
  Yunho Jung, Jong Wook Kim, Jeong-Sik Byeon, Hoon Sup Koo, Sun-Jin Boo, Jun Lee, Young Hwangbo, Yoon Mi Jeen, Hyun Gun Kim
  Digestive Diseases and Sciences.2018; 63(10): 2773.     CrossRef
• Perforation and Postoperative Bleeding Associated with Endoscopic Submucosal Dissection in Colorectal Tumors: An Analysis of 398 Lesions Treated in Saga, Japan
  Koji Yamamoto, Ryo Shimoda, Shinichi Ogata, Megumi Hara, Yoichiro Ito, Naoyuki Tominaga, Atsushi Nakayama, Yasuhisa Sakata, Nanae Tsuruoka, Ryuichi Iwakiri, Kazuma Fujimoto
  Internal Medicine.2018; 57(15): 2115.     CrossRef
• The efficacy of the pocket-creation method for cases with severe fibrosis in colorectal endoscopic submucosal dissection
  Naohisa Yoshida, Yuji Naito, Ritsu Yasuda, Takaaki Murakami, Ryohei Hirose, Kiyoshi Ogiso, Yutaka Inada, Hideyuki Konishi, Rafiz Abdul Rani, Mitsuo Kishimoto, Eiichi Konishi, Masayoshi Nakanishi, Yoshito Itoh
  Endoscopy International Open.2018; 06(08): E975.     CrossRef
• Local recurrence and subsequent endoscopic treatment after endoscopic piecemeal mucosal resection with or without precutting in the colorectum
  Myeongsook Seo, Eun Mi Song, Gwang Un Kim, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Byong Duk Ye, Seung-Jae Myung, Suk-Kyun Yang, Jeong-Sik Byeon
  Intestinal Research.2017; 15(4): 502.     CrossRef

Citations

Citations to this article as recorded by  

• Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
  Yu Kyung Jun, Seong-Joon Koh, Dae Seong Myung, Sang Hyoung Park, Choon Jin Ooi, Ajit Sood, Jong Pil Im
  Intestinal Research.2023; 21(3): 353.     CrossRef
• Treatment of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
  Eun Mi Song, Soo-Young Na, Sung Noh Hong, Siew Chien Ng, Tadakazu Hisamatsu, Byong Duk Ye
  Intestinal Research.2023; 21(3): 339.     CrossRef
• IBD barriers across the continents – East Asia
  Joyce Wing Yan Mak, Agnes Hiu Yan Ho, Siew Chien Ng
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Venous Thromboembolism Risk in Asian Patients with Inflammatory Bowel Disease: A Population-Based Nationwide Inception Cohort Study
  Su Young Kim, Yeon Seo Cho, Hyun-Soo Kim, Jung Kuk Lee, Hee Man Kim, Hong Jun Park, Hyunil Kim, Jihoon Kim, Dae Ryong Kang
  Gut and Liver.2022; 16(4): 555.     CrossRef
• Risk of venous thromboembolism in Asian patients with inflammatory bowel disease: a nationwide cohort study
  Chan Mi Heo, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Mi Yang, Seonwoo Kim, Young-Ho Kim
  Scientific Reports.2021;[Epub]     CrossRef
• Incidence and risk factors for venous thrombosis among patients with inflammatory bowel disease in China: a multicenter retrospective study
  Jing Liu, Xiang Gao, Ye Chen, Qiao Mei, Liangru Zhu, Jiaming Qian, Pinjin Hu, Qian Cao
  Intestinal Research.2021; 19(3): 313.     CrossRef
• Anti-tumor Necrosis Factor Agents and Tuberculosis in Inflammatory Bowel Disease
  Yunho Jung
  The Korean Journal of Gastroenterology.2020; 75(1): 1.     CrossRef
• Challenges in the diagnosis and management of inflammatory bowel disease in resource-limited settings in Asia
  Rupa Banerjee, Partha Pal, Joyce Wing Yan Mak, Siew C Ng
  The Lancet Gastroenterology & Hepatology.2020; 5(12): 1076.     CrossRef
• Quality of care in inflammatory bowel disease: actual health service experiences fall short of the standards
  Antonina Mikocka‐Walus, Wayne Massuger, Simon R. Knowles, Gregory T. Moore, Stephanie Buckton, William Connell, Paul Pavli, Leanne Raven, Jane M. Andrews
  Internal Medicine Journal.2020; 50(10): 1216.     CrossRef
• Improving the quality of care for inflammatory bowel disease
  Byong Duk Ye, Simon Travis
  Intestinal Research.2019; 17(1): 45.     CrossRef
• Should Asian inflammatory bowel disease patients need routine thromboprophylaxis?
  Meng-Tzu Weng, Chien-Chih Tung, Jau-Min Wong, Shu-Chen Wei
  Intestinal Research.2018; 16(2): 312.     CrossRef
• Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policies
  Lorant Gonczi, Zsuzsanna Kurti, Petra Anna Golovics, Barbara Dorottya Lovasz, Orsolya Menyhart, Anna Seres, Liza Dalma Sumegi, Alexander Gal, Akos Ilias, Papp Janos, Krisztina Barbara Gecse, Talat Bessisow, Waqqas Afif, Alain Bitton, Zsuzsanna Vegh, Peter
  Digestive and Liver Disease.2018; 50(1): 37.     CrossRef
• Quality indicators in inflammatory bowel disease
  Sameer K. Berry, Gil Y. Melmed
  Intestinal Research.2018; 16(1): 43.     CrossRef
• Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti‐tumor necrosis factor treatment. Part 1: Risk assessment
  Dong II Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin‐Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasu
  Journal of Gastroenterology and Hepatology.2018; 33(1): 20.     CrossRef
• Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment
  Dong Il Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin-Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasu
  Intestinal Research.2018; 16(1): 4.     CrossRef
• Incidence and Risk Factor Analysis of Thromboembolic Events in East Asian Patients With Inflammatory Bowel Disease, a Multinational Collaborative Study
  Meng-Tzu Weng, Sang Hyoung Park, Katsuyoshi Matsuoka, Chien-Chih Tung, Jae Yong Lee, Chin-Hao Chang, Suk-Kyun Yang, Mamoru Watanabe, Jau-Min Wong, Shu-Chen Wei
  Inflammatory Bowel Diseases.2018; 24(8): 1791.     CrossRef
• Assessment of factors associated with smoking cessation at diagnosis or during follow‐up of Crohn's disease
  Eun Mi Song, Gwang‐Un Kim, Myeongsook Seo, Sung Wook Hwang, Sang Hyoung Park, Eunja Kwon, Ho‐Su Lee, Dong‐Hoon Yang, Kyung‐Jo Kim, Byong Duk Ye, Jeong‐Sik Byeon, Seung‐Jae Myung, Suk‐Kyun Yang
  Journal of Gastroenterology and Hepatology.2018; 33(1): 180.     CrossRef
• Quality of care in inflammatory bowel diseases: What is the best way to better outcomes?
  Matthew Strohl, Lorant Gonczi, Zsuzsanna Kurt, Talat Bessissow, Peter L Lakatos
  World Journal of Gastroenterology.2018; 24(22): 2363.     CrossRef
• Changing treatment paradigms for the management of inflammatory bowel disease
  Jong Pil Im, Byong Duk Ye, You Sun Kim, Joo Sung Kim
  The Korean Journal of Internal Medicine.2018; 33(1): 28.     CrossRef
• IBD2020 global forum: results of an international patient survey on quality of care
  Peter Irving, Johan Burisch, Richard Driscoll, Mats Olsson, John R Fullarton, Barry S Rodgers-Gray, Simon PL Travis
  Intestinal Research.2018; 16(4): 537.     CrossRef

Citations

Citations to this article as recorded by  

• Endoscopic findings in the upper gastrointestinal tract in patients with Crohn’s disease are common, highly specific, and associated with chronic gastritis
  Katarzyna Graca-Pakulska, Wojciech Błogowski, Iwona Zawada, Anna Deskur, Krzysztof Dąbkowski, Elżbieta Urasińska, Teresa Starzyńska
  Scientific Reports.2023;[Epub]     CrossRef
• Detection Rates of Non-Cavitary Epithelioid Cell Granuloma by Gastrointestinal Biopsy in Patients with Treatment-Naïve Crohn’s Disease
  Katsuya Endo, Yoko Kawakami, Yuki Yoshino, Shiho Kondo, Daisuke Fukushi, Atsuko Takasu, Takayuki Kogure, Morihisa Hirota, Kazuhiro Murakami, Kennichi Satoh
  Inflammatory Intestinal Diseases.2023; 8(3): 105.     CrossRef
• Beyond Helicobacter: dealing with other variants of gastritis—an algorithmic approach
  Hala El‐Zimaity, Robert H Riddell
  Histopathology.2021; 78(1): 48.     CrossRef
• Endoscopic and Histopathological Findings of the Esophagus, Stomach, and Duodenum in Patients with Crohn’s Disease from a Reference Center in Bahia, Brazil
  Andrea Maia Pimentel, Luiz Antônio Rodrigues de Freitas, Rita de Cássia Reis Cruz, Isaac Neri de Novais Silva, Laíla Damasceno Andrade, Paola Nascimento Marques, Júlia Cordeiro Braga, Flora Maria Lorenzo Fortes, Katia Rejane Marques Brito, Jaciane Araújo
  Clinics and Practice.2021; 11(2): 374.     CrossRef
• The gastric microbiota in patients with Crohn’s disease; a preliminary study
  Jerzy Ostrowski, Maria Kulecka, Iwona Zawada, Natalia Żeber-Lubecka, Agnieszka Paziewska, Katarzyna Graca-Pakulska, Krzysztof Dąbkowski, Karolina Skubisz, Patrycja Cybula, Filip Ambrożkiewicz, Elżbieta Urasińska, Michał Mikula, Teresa Starzyńska
  Scientific Reports.2021;[Epub]     CrossRef
• Associations between the Presence of Granulomata and Disease Phenotype and Outcomes in Children Diagnosed with Crohn’s Disease
  Laura Appleton, Euan Watt, Fiona Jagger, Richard Hansen, Richard B. Gearry, Andrew S. Day
  Gastrointestinal Disorders.2020; 2(2): 164.     CrossRef
• Ovarian Crohn’s Disease: A Case Report and Review of the Literature
  Hamza Mohammed, Rana Bokhary, Mohammed Nassif, Mahmoud Mosli, Haruhiko Sugimura
  Case Reports in Gastrointestinal Medicine.2020; 2020: 1.     CrossRef
• Crohn’s disease of esophagus, stomach and duodenum
  Andréa Maia Pimentel, Raquel Rocha, Genoile Oliveira Santana
  World Journal of Gastrointestinal Pharmacology and Therapeutics.2019; 10(2): 35.     CrossRef
• Prognostic significance of granulomas in children with Crohn’s disease
  Benjamin Rothschild, Firas Rinawi, Yonatan Herman, Osnat Nir, Raanan Shamir, Amit Assa
  Scandinavian Journal of Gastroenterology.2017; 52(6-7): 716.     CrossRef
• Endoscopic Bamboo Joint-like Appearance of the Stomach in Crohn's Disease
  Kwang Il Seo, Won Moon
  The Korean Journal of Gastroenterology.2017; 69(2): 151.     CrossRef
• Characteristics of Upper Gastrointestinal Tract Involvement in Korean Pediatric Crohn's Disease: A Multicenter Study
  Ji Hyoung Park, Hye Na Nam, Ji-Hyuk Lee, Jeana Hong, Dae Yong Yi, Eell Ryoo, In Sang Jeon, Hann Tchah
  Pediatric Gastroenterology, Hepatology & Nutrition.2017; 20(4): 227.     CrossRef
• Increased duodenal expression of miR-146a and -155 in pediatric Crohn’s disease
  Dániel Szűcs, Nóra Judit Béres, Réka Rokonay, Kriszta Boros, Katalin Borka, Zoltán Kiss, András Arató, Attila J Szabó, Ádám Vannay, Erna Sziksz, Csaba Bereczki, Gábor Veres
  World Journal of Gastroenterology.2016; 22(26): 6027.     CrossRef

Inflammatory bowel disease (IBD) is defined as a chronic and relapsing inflammatory disorder of the intestine. Intestinal inflammation in IBD has been proposed to be attributable to the interplay between microbial, genetic, environmental, and immunological factors. The incidence and prevalence rates of IBD are rapidly increasing apparently in other parts of the world, with dramatic increases especially in East Asia. Generally, cohort studies are useful for estimating the incidence, prevalence, natural course, prognosis, and risk factors of diseases. In particular, cohort studies performed in Western countries have well described the prevalence, risk factors, and natural course of IBD and investigated its genetic pathophysiology. However, the outcomes of IBD cohort studies performed in Korea are not as persuasive as those of Western studies because of the relatively low prevalence of IBD and short follow-up periods of the cohorts in Korea. Despite this critical limitation, members of the Korean Association for the Study of Intestinal Diseases have demonstrated outstanding results. Some unique features of IBD patients in Korea are well demonstrated, such as thiopurine-induced leukopenia or risks of opportunistic tuberculosis infection in patients receiving tumor necrosis factor-α inhibitors. In this review, the present authors summarized the key points of the results of the cohort studies performed in Korea and explored future perspectives.

Citations

Citations to this article as recorded by  

• CXCL10 as a shared specific marker in rheumatoid arthritis and inflammatory bowel disease and a clue involved in the mechanism of intestinal flora in rheumatoid arthritis
  Yin Guan, Yue Zhang, Yifan Zhu, Yue Wang
  Scientific Reports.2023;[Epub]     CrossRef
• Plasma miRNA Profile of Crohn’s Disease and Rheumatoid Arthritis Patients
  Tatiana D. Saccon, Joseph M. Dhahbi, Augusto Schneider, Yury O. Nunez Lopez, Ahmad Qasem, Marcelo B. Cavalcante, Lauren K. Sing, Saleh A. Naser, Michal M. Masternak
  Biology.2022; 11(4): 508.     CrossRef
• Inflammatory bowel disease in Korea: epidemiology and pathophysiology
  Jung Won Lee, Chang Soo Eun
  The Korean Journal of Internal Medicine.2022; 37(5): 885.     CrossRef
• Effect of Age on the Initiation of Biologic Agent Therapy in Patients With Inflammatory Bowel Disease: Korean Common Data Model Cohort Study
  Youn I Choi, Yoon Jae Kim, Jun-Won Chung, Kyoung Oh Kim, Hakki Kim, Rae Woong Park, Dong Kyun Park
  JMIR Medical Informatics.2020; 8(4): e15124.     CrossRef
• Patterns of Ulcerative Colitis Treatments and Factors Affecting the Prescribing of Systemic Corticosteroid using Health Insurance Claims Database
  Jiyool Kim, So-Hee Park, Ju-Young Shin
  Korean Journal of Clinical Pharmacy.2020; 30(2): 102.     CrossRef
• Association study between two polymorphisms of tumor necrosis factor ligand superfamily member 15 (TNFSF15) gene and ulcerative colitis in south‐west of Iran
  Marzieh Taheri, Pegah Ghandil, Seyyed Jalal Hashemi, Mehri Ghafourian, Abdol Rahim Masjedi Zadeh, Ata Allah Ghadiri
  Journal of Cellular Biochemistry.2019; 120(5): 8784.     CrossRef
• A new opportunity for innovative inflammatory bowel disease research: the moderate-to-severe ulcerative colitis in Korea (MOSAIK) cohort study
  Chang Kyun Lee, Kang-Moon Lee, Dong Il Park, Sung-Ae Jung, Yoon Tae Jeen, Young Sook Park, Hyo Jong Kim
  Intestinal Research.2019; 17(1): 1.     CrossRef
• Dermatologic Manifestations in Inflammatory Bowel Disease
  Hyun Yi Suh, Woo Jin Lee, Soo-Young Na
  The Korean Journal of Gastroenterology.2019; 73(5): 285.     CrossRef
• Depressive Symptoms and Quality of Life in the Patients of Inflammatory Bowel Disease
  Jung Won Lee
  Gut and Liver.2017; 11(4): 449.     CrossRef
• Association of inflammatory bowel disease with ankylosing spondylitis and rheumatoid arthritis: A nationwide population-based study
  Jung Min Bae, Ji Yoon Choo, Ki-Jo Kim, Kyung-Su Park
  Modern Rheumatology.2017; 27(3): 435.     CrossRef
• Ophthalmologic manifestations in patients with inflammatory bowel disease
  Hye Jin Lee, Hyun Joo Song, Jin Ho Jeong, Heung Up Kim, Sun-Jin Boo, Soo-Young Na
  Intestinal Research.2017; 15(3): 380.     CrossRef
• Hydrogen-rich water protects against inflammatory bowel disease in mice by inhibiting endoplasmic reticulum stress and promoting heme oxygenase-1 expression
  Nai-Ying Shen, Jian-Bin Bi, Jing-Yao Zhang, Si-Min Zhang, Jing-Xian Gu, Kai Qu, Chang Liu
  World Journal of Gastroenterology.2017; 23(8): 1375.     CrossRef
• Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal Diseases
  Young Sun Kim, Sung-Ae Jung, Kang-Moon Lee, Soo Jung Park, Tae Oh Kim, Chang Hwan Choi, Hyun Gun Kim, Won Moon, Chang Mo Moon, Hye Kyoung Song, Soo-Young Na, Suk-Kyun Yang
  Intestinal Research.2017; 15(3): 338.     CrossRef
• Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn’s Disease: Results from the CONNECT Study
  Jee Hye Kwon, Jong Pil Im, Byong Duk Ye, Jae Hee Cheon, Hyun Joo Jang, Kang Moon Lee, You Sun Kim, Sang Wook Kim, Young Ho Kim, Geun Am Song, Dong Soo Han, Won Ho Kim, Joo Sung Kim
  Gut and Liver.2016; 10(4): 595.     CrossRef
• Crohn's disease confined to the duodenum: A case report
  Dong Jin Song, Il Soon Whang, Hyung Wook Choi, Cheol Yun Jeong, Sung Hoon Jung
  World Journal of Clinical Cases.2016; 4(6): 146.     CrossRef
• Importance of Patients’ Knowledge of Their Prescribed Medication in Improving Treatment Adherence in Inflammatory Bowel Disease
  Chung Hyun Tae, Sung-Ae Jung, Hye Sung Moon, Jung-A Seo, Hye Kyung Song, Chang Mo Moon, Seong-Eun Kim, Ki-Nam Shim, Hye-Kyung Jung
  Journal of Clinical Gastroenterology.2016; 50(2): 157.     CrossRef
• Fusobacterium Isolates Recovered From Colonic Biopsies of Inflammatory Bowel Disease Patients in Korea
  Yangsoon Lee, Chang Soo Eun, A Reum Lee, Chan Hyuk Park, Dong Soo Han
  Annals of Laboratory Medicine.2016; 36(4): 387.     CrossRef
• Crohn's disease prognosis and early immunomodulator therapy: Results from the CONNECT study
  Bun Kim, Jae Hee Cheon, Hyun Jin Moon, Yi Rang Park, Byong Duk Ye, Suk‐Kyun Yang, Geom Seog Seo, Byung Ik Jang, You Sun Kim, Joo Sung Kim, Dong Soo Han, Young‐Ho Kim, Won Ho Kim
  Journal of Gastroenterology and Hepatology.2016; 31(1): 126.     CrossRef

The incidence and prevalence of inflammatory bowel disease (IBD) in Asia has witnessed a rapid increase within a few decades. The genetic susceptibility and epidemiologic backgrounds in the Asian population have been found to be different from that of Western populations. There is an extensive crosstalk between gut microbiota and human hosts, with evidence of reciprocal interactions. It is well known that gut microbiota can affect the host immune system and in turn, host genetic backgrounds can affect gut microbiota reciprocally. Evidences have implicated gut microbes in the development of IBD, but no causative microorganisms have been identified. Recent advances in sequencing technology and computational analysis have now made identification of complex gut microbiomes accessible. Further research targeting gut microbiota could help in identifying biomarkers to predict clinical response, and therapeutic modalities that might affect their resilience.

Citations

Citations to this article as recorded by  

• Long‐term effects of fecal microbiota transplantation on gut microbiota after Helicobacter pylori eradication with bismuth quadruple therapy: A randomized controlled trial
  Jing‐Tao Zhao, Yi Zhang, Xing‐Wei Wang, Pei‐Ying Zou, Zhe Zhao, Hao Mei, Yu‐Xiang Liu, Na‐Yun Su, Yang‐Jie Zhu, Bin Wang, Yan‐Ling Wei, Dong‐Feng Chen, Chun‐Hui Lan
  Helicobacter.2024;[Epub]     CrossRef
• A COMBINATION REVIEW ON EFFECT OF CITRUS JUICE AND METRONIDAZOLE IN INFLAMMATORY BOWEL DISEASE
  Deeksha, Shalini Saini, Meenakshi Bhatt
  International Journal of Research -GRANTHAALAYAH.2023;[Epub]     CrossRef
• Dysbiosis, Host Metabolism, and Non-communicable Diseases: Trialogue in the Inborn Errors of Metabolism
  Chiara Montanari, Sara Parolisi, Elisa Borghi, Lorenza Putignani, Giulia Bassanini, Juri Zuvadelli, Cristina Bonfanti, Albina Tummolo, Carlo Dionisi Vici, Giacomo Biasucci, Alberto Burlina, Maria Teresa Carbone, Elvira Verduci
  Frontiers in Physiology.2021;[Epub]     CrossRef
• Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis
  Katsuyoshi Matsuoka, Yukari Uemura, Takanori Kanai, Reiko Kunisaki, Yasuo Suzuki, Kaoru Yokoyama, Naoki Yoshimura, Toshifumi Hibi
  Digestive Diseases and Sciences.2018; 63(7): 1910.     CrossRef
• Effects of the Administration of Probiotics on Fecal Microbiota Diversity and Composition in Healthy Individuals
  Choong-Kyun Noh, Bong Sun Kim, Gana Hong, Jae Youn Cheong, Kwang Jae Lee
  Journal of Neurogastroenterology and Motility.2018; 24(3): 452.     CrossRef
• Chlorogenic acid suppresses lipopolysaccharide-induced nitric oxide and interleukin-1β expression by inhibiting JAK2/STAT3 activation in RAW264.7 cells
  Sang-Hun Kim, Sun-Young Park, Young-Lan Park, Dae-Seong Myung, Jong-Sun Rew, Young-Eun Joo
  Molecular Medicine Reports.2017; 16(6): 9224.     CrossRef
• Metronidazole-induced encephalopathy in a patient with Crohn's disease
  Jihye Kim, Jaeyoung Chun, Jae Yong Park, Seung Wook Hong, Joo Young Lee, Jin Woo Kang, Seongjun Hwang, Sang-Bae Ko, Jong Pil Im, Joo Sung Kim
  Intestinal Research.2017; 15(1): 124.     CrossRef
• The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review
  Rosario Lucas López, María José Grande Burgos, Antonio Gálvez, Rubén Pérez Pulido
  APMIS.2017; 125(1): 3.     CrossRef
• Can Proton Pump Inhibitors Increase Incidence of Nonsteroidal Anti-inflammatory Drug-induced Small Bowel Injury?
  Seong Ran Jeon
  The Korean Journal of Gastroenterology.2016; 68(2): 123.     CrossRef
• The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial
  Bumjo Oh, Bong‐Soo Kim, Ji Won Kim, Jong Seung Kim, Seong‐Joon Koh, Byeong Gwan Kim, Kook Lae Lee, Jongsik Chun
  Helicobacter.2016; 21(3): 165.     CrossRef
• Does the intestinal microbial community of Korean Crohn’s disease patients differ from that of western patients?
  Chang Soo Eun, Min-Jung Kwak, Dong Soo Han, A. Reum Lee, Dong Il Park, Suk-Kyun Yang, Yong Seok Kim, Jihyun F. Kim
  BMC Gastroenterology.2016;[Epub]     CrossRef
• Phenylketonuria and Gut Microbiota: A Controlled Study Based on Next-Generation Sequencing
  Felipe Pinheiro de Oliveira, Roberta Hack Mendes, Priscila Thiago Dobbler, Volker Mai, Victor Salter Pylro, Sheldon G Waugh, Filippo Vairo, Lilia Farret Refosco, Luiz Fernando Würdig Roesch, Ida Vanessa Doederlein Schwartz, Brenda A Wilson
  PLOS ONE.2016; 11(6): e0157513.     CrossRef
• Metabolome of human gut microbiome is predictive of host dysbiosis
  Peter E. Larsen, Yang Dai
  GigaScience.2015;[Epub]     CrossRef
• Alteration of Fecal Microbiota in Patients With Postinfectious Irritable Bowel Syndrome (Gut 2014;63:1737-1745)
  Young-Eun Joo
  Journal of Neurogastroenterology and Motility.2015; 21(1): 135.     CrossRef
• Does the Cyclosporine Still Have a Potential Role in the Treatment of Acute Severe Steroid-Refractory Ulcerative Colitis?
  Chang Soo Eun, Dong Soo Han
  Gut and Liver.2015;[Epub]     CrossRef
• Cross-Regulation of Innate and Adaptive Immunity: A New Perspective for the Pathogenesis of Inflammatory Bowel Disease
  Da Yeon Oh, Seong-Joon Koh
  Gut and Liver.2015;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Modern treatment of perianal fistulas following Crohn’s disease
  A.L. Bejanyan, A.A. Bumbazhai, K.N. Petrenko, A.A. Sumbaev, A.V. Matinyan, I.I. Eremin
  Regenerative biotechnologies, preventive, digital and predictive medicine.2024; 1(2): 49.     CrossRef
• Inflammatory bowel disease in Korea: epidemiology and pathophysiology
  Jung Won Lee, Chang Soo Eun
  The Korean Journal of Internal Medicine.2022; 37(5): 885.     CrossRef
• Clinical Characteristics of Korean Patients with Elderly-Onset Crohn’s Disease: Results from the Prospective CONNECT Study
  You Sun Kim, Min Jeong Na, Byong Duk Ye, Jae Hee Cheon, Jong Pil Im, Joo Sung Kim
  Gut and Liver.2022; 16(6): 995.     CrossRef
• Clinical Features and Long-term Prognosis of Crohn’s Disease in Korea: Results from the Prospective CONNECT Study
  Seung Wook Hong, Byong Duk Ye, Jae Hee Cheon, Ji Hyun Lee, Ja Seol Koo, Byung Ik Jang, Kang-Moon Lee, You Sun Kim, Tae Oh Kim, Jong Pil Im, Geun Am Song, Sung-Ae Jung, Hyun Soo Kim, Dong Il Park, Hyun-Soo Kim, Kyu Chan Huh, Young-Ho Kim, Jae Myung Cha, Ge
  Gut and Liver.2022; 16(6): 907.     CrossRef
• Treatment Strategy for Perianal Fistulas in Crohn Disease Patients: The Surgeon’s Point of View
  Jong Lyul Lee, Yong Sik Yoon, Chang Sik Yu
  Annals of Coloproctology.2021; 37(1): 5.     CrossRef
• Epidemiology and diagnosis of inflammatory bowel diseases
  Kang-Moon Lee
  Journal of the Korean Medical Association.2021; 64(9): 579.     CrossRef
• Clinical Features of Intra-Abdominal Abscess and Intestinal Free-Wall Perforation in Korean Patients with Crohn’s Disease: Results from the CONNECT Study
  Seok-Hoo Jeong, Ja Sung Choi, Jin Woo Kim, Hee Man Kim, Hyun-Soo Kim, Jong Pil Im, Joo Sung Kim, You Sun Kim, Jae Hee Cheon, Won Ho Kim, Byong Duk Ye, Young-Ho Kim, Dong Soo Han
  Journal of Clinical Medicine.2020; 10(1): 116.     CrossRef
• Iranian Registry of Crohn’s and Colitis: study profile of first nation-wide inflammatory bowel disease registry in Middle East
  Masoud M Malekzadeh, Alireza Sima, Sudabeh Alatab, Anahita Sadeghi, Nasser Ebrahimi Daryani, Payman Adibi, Iradj Maleki, Hassan Vossoughinia, Hafez Fakheri, Abbas Yazdanbod, Seyed Alireza Taghavi, Rahim Aghazadeh, Mohammad Hassan Somi, Kazem Zendedel, Hom
  Intestinal Research.2019; 17(3): 330.     CrossRef
• Postoperative course of Crohn disease according to timing of bowel resection
  Ji Min Lee, Kang-Moon Lee, Joo Sung Kim, You Sun Kim, Jae Hee Cheon, Byong Duk Ye, Young-Ho Kim, Dong Soo Han, Chang Kyun Lee, Hyun-Ju Park
  Medicine.2018; 97(16): e0459.     CrossRef
• Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study
  Jaeyoung Chun, Jong Pil Im, Ji Won Kim, Kook Lae Lee, Chang Hwan Choi, Hyunsoo Kim, Jae Hee Cheon, Byong Duk Ye, Young-Ho Kim, You Sun Kim, Yoon Tae Jeen, Dong Soo Han, Won Ho Kim, Joo Sung Kim
  Gut and Liver.2018; 12(5): 544.     CrossRef
• Second Korean Guidelines for the Management of Crohn's Disease
  Jae Jun Park, Suk-Kyun Yang, Byong Duk Ye, Jong Wook Kim, Dong Il Park, Hyuk Yoon, Jong Pil Im, Kang Moon Lee, Sang Nam Yoon, Heeyoung Lee
  The Korean Journal of Gastroenterology.2017; 69(1): 29.     CrossRef
• Second Korean guidelines for the management of Crohn's disease
  Jae Jun Park, Suk-Kyun Yang, Byong Duk Ye, Jong Wook Kim, Dong Il Park, Hyuk Yoon, Jong Pil Im, Kang Moon Lee, Sang Nam Yoon, Heeyoung Lee
  Intestinal Research.2017; 15(1): 38.     CrossRef
• Serum Adipocytokine Levels as Surrogate Markers for Disease Activity of Crohn’s Disease
  Su Hwan Kim, Seung Hyeon Jang, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee, You Sun Kim, Dong Soo Han, Joo Sung Kim
  The American Journal of the Medical Sciences.2017; 353(5): 439.     CrossRef
• A coding variant inFTOconfers susceptibility to thiopurine-induced leukopenia in East Asian patients with IBD
  Han Sang Kim, Jae Hee Cheon, Eun Suk Jung, Joonhee Park, Sowon Aum, Soo Jung Park, Sungho Eun, Jinu Lee, Ulrich Rüther, Giles S H Yeo, Marcella Ma, Kyong Soo Park, Takeo Naito, Yoichi Kakuta, Ji Hyun Lee, Won Ho Kim, Min Goo Lee
  Gut.2017; 66(11): 1926.     CrossRef
• Development of a Novel Predictive Model for the Clinical Course of Crohnʼs Disease
  Yehyun Park, Jae Hee Cheon, Yi Lang Park, Byong Duk Ye, You Sun Kim, Dong Soo Han, Joo Sung Kim, Sung Noh Hong, Young Ho Kim, Seong Ran Jeon, Won Ho Kim
  Inflammatory Bowel Diseases.2017; 23(7): 1071.     CrossRef
• Influence of age at diagnosis on the clinical characteristics of Crohn's disease in Korea: Results from the CONNECT study
  Sung Wook Hwang, Jee Hyun Kim, Jong Pil Im, Byong Duk Ye, Hoon Sup Koo, Kyu Chan Huh, Jae Hee Cheon, You Sun Kim, Young Ho Kim, Dong Soo Han, Won Ho Kim, Joo Sung Kim
  Journal of Gastroenterology and Hepatology.2017; 32(10): 1716.     CrossRef
• Crohn's disease prognosis and early immunomodulator therapy: Results from the CONNECT study
  Bun Kim, Jae Hee Cheon, Hyun Jin Moon, Yi Rang Park, Byong Duk Ye, Suk‐Kyun Yang, Geom Seog Seo, Byung Ik Jang, You Sun Kim, Joo Sung Kim, Dong Soo Han, Young‐Ho Kim, Won Ho Kim
  Journal of Gastroenterology and Hepatology.2016; 31(1): 126.     CrossRef
• Deep resequencing of 131 Crohn's disease associated genes in pooled DNA confirmed three reported variants and identified eight novel variants
  Sung Noh Hong, Changho Park, Soo Jung Park, Chang Kyun Lee, Byong Duk Ye, You Sun Kim, Seungbok Lee, Jeesoo Chae, Jong-Il Kim, Young-Ho Kim
  Gut.2016; 65(5): 788.     CrossRef
• Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn’s Disease: Results from the CONNECT Study
  Jee Hye Kwon, Jong Pil Im, Byong Duk Ye, Jae Hee Cheon, Hyun Joo Jang, Kang Moon Lee, You Sun Kim, Sang Wook Kim, Young Ho Kim, Geun Am Song, Dong Soo Han, Won Ho Kim, Joo Sung Kim
  Gut and Liver.2016; 10(4): 595.     CrossRef
• The clinical characteristics of patients with free perforation in Korean Crohn’s disease: results from the CONNECT study
  Young Seok Doh, You Sun Kim, Song I Bae, Jong Pil Im, Jae Hee Cheon, Byong Duk Ye, Ji Won Kim, Young Sook Park, Ji Hyun Lee, Young-Ho Kim, Joo Sung Kim, Dong Soo Han, Won Ho Kim
  BMC Gastroenterology.2015;[Epub]     CrossRef
• Clinical Factors and Disease Course Related to Diagnostic Delay in Korean Crohn’s Disease Patients: Results from the CONNECT Study
  Chang Mo Moon, Sung-Ae Jung, Seong-Eun Kim, Hyun Joo Song, Yunho Jung, Byong Duk Ye, Jae Hee Cheon, You Sun Kim, Young-Ho Kim, Joo Sung Kim, Dong Soo Han, Mathias Chamaillard
  PLOS ONE.2015; 10(12): e0144390.     CrossRef
• Long-term Clinical Outcomes of Urban Versus Rural Environment in Korean Patients with Crohn's Disease: Results from the CONNECT Study
  Y. S. Jung, D. I. Park, B. D. Ye, J. H. Cheon, Y. S. Kim, Y. H. Kim, J. S. Kim, H. S. Chae, G. H. Baik, D. S. Han
  Journal of Crohn's and Colitis.2015; 9(3): 246.     CrossRef
• Inflammatory Bowel Disease Cohort Studies in Korea: Present and Future
  Jung Won Lee, Jong Pil Im, Jae Hee Cheon, You Sun Kim, Joo Sung Kim, Dong Soo Han
  Intestinal Research.2015; 13(3): 213.     CrossRef
• Institutional Board Review for Clinical Investigations on Inflammatory Bowel Diseases: A Single-Center Study
  Sinyoung Park, Yang Hee Noh, Sun Young Rha, Won Ho Kim, Jae Hee Cheon
  Intestinal Research.2015; 13(3): 274.     CrossRef
• Crohn's disease in Korea: past, present, and future
  Kang-Moon Lee, Ji Min Lee
  The Korean Journal of Internal Medicine.2014; 29(5): 558.     CrossRef

Citations

Citations to this article as recorded by  

• Intestinal tuberculosis with small bowel stricture and hemorrhage as the predominant manifestation: Three case reports
  Gang Huang, Kang-Kang Wu, Xiao-Na Li, Jing-Hua Kuai, Ai-Jun Zhang
  World Journal of Gastrointestinal Surgery.2024; 16(1): 248.     CrossRef
• Digestive Tract Tuberculosis Guideline
  Mohamed Tahiri, Khean-Lee Goh, Zaigham Abbas, David Epstein, Chen Min-Hu, Chris J.J. Mulder, Amarender Singh Puri, Michael Schultz, Anton LeMair, Jim Melberg
  Journal of Clinical Gastroenterology.2023; 57(7): 643.     CrossRef
• Visceral Fat Indices: Do They Help Differentiate Crohn’s Disease and Intestinal Tuberculosis in Children?
  Jayendra Seetharaman, Anshu Srivastava, Rajanikant R Yadav, Sumit K Singh, Prabhakar Mishra, Moinak Sen Sarma, Ujjal Poddar
  Journal of Crohn's and Colitis.2023; 17(12): 2026.     CrossRef
• Differentiating gastrointestinal tuberculosis and Crohn's disease- a comprehensive review
  Arup Choudhury, Jasdeep Dhillon, Aravind Sekar, Pankaj Gupta, Harjeet Singh, Vishal Sharma
  BMC Gastroenterology.2023;[Epub]     CrossRef
• Differentiating intestinal tuberculosis and Crohn disease: Quo Vadis
  Vishal Sharma
  Expert Review of Gastroenterology & Hepatology.2020; 14(8): 647.     CrossRef
• Differentiating Crohn’s disease from intestinal tuberculosis
  Saurabh Kedia, Prasenjit Das, Kumble Seetharama Madhusudhan, Siddhartha Dattagupta, Raju Sharma, Peush Sahni, Govind Makharia, Vineet Ahuja
  World Journal of Gastroenterology.2019; 25(4): 418.     CrossRef
• The Adipokine Metrnl Ameliorates Chronic Colitis in Il-10–/– Mice by Attenuating Mesenteric Adipose Tissue Lesions During Spontaneous Colitis
  Lugen Zuo, Sitang Ge, Yuanyuan Ge, Jingjing Li, Bing Zhu, Zongbing Zhang, Congqiao Jiang, Jing Li, Suanhu Wang, Mulin Liu, Shiqing Li, Rong Wu, Jianguo Hu
  Journal of Crohn's and Colitis.2019; 13(7): 931.     CrossRef
• Indian guidelines on imaging of the small intestine in Crohn’s disease: A joint Indian Society of Gastroenterology and Indian Radiology and Imaging Association consensus statement
  Saurabh Kedia, Raju Sharma, Govind Makharia, Vineet Ahuja, Devendra Desai, Devasenathipathy Kandasamy, Anu Eapen, Karthik Ganesan, Uday C Ghosha, Naveen Kalra, R Karthikeyan, Kumble Seetharama Madhusudhan, Mathew Philip, Amarender Puri, Sunil Puri, Saroj
  Indian Journal of Radiology and Imaging.2019; 29(02): 111.     CrossRef
• Serum proteome profiles to differentiate Crohn disease from intestinal tuberculosis and primary intestinal lymphoma
  Longgui Ning, Guodong Shan, Zeyu Sun, Xinhe Lou, Fenming Zhang, Sha Li, Haojie Du, Jinghua Yu, Hongtan Chen, Guoqiang Xu
  Medicine.2019; 98(50): e18304.     CrossRef
• Creeping fat in patients with ileo‐colonic Crohn's disease correlates with disease activity and severity of inflammation: A preliminary study using energy spectral computed tomography
  Qi Feng, Xi Tao Xu, Yi Zhou, Yun Qi Yan, Zhi Hua Ran, Jiong Zhu
  Journal of Digestive Diseases.2018; 19(8): 475.     CrossRef
• Making a Positive Diagnosis of Intestinal Tuberculosis with the Aid of New Biologic and Histologic Features: How Far Have We Reached?
  Vatsal Mehta, Devendra Desai, Philip Abraham, Camilla Rodrigues
  Inflammatory Intestinal Diseases.2018; 3(4): 155.     CrossRef
• Accuracy of computed tomographic features in differentiating intestinal tuberculosis from Crohn's disease: a systematic review with meta-analysis
  Saurabh Kedia, Raju Sharma, Vishnubhatla Sreenivas, Kumble Seetharama Madhusudhan, Vishal Sharma, Sawan Bopanna, Venigalla Pratap Mouli, Rajan Dhingra, Dawesh Prakash Yadav, Govind Makharia, Vineet Ahuja
  Intestinal Research.2017; 15(2): 149.     CrossRef
• Development and validation of visceral fat quantification as a surrogate marker for differentiation of Crohn's disease and intestinal tuberculosis
  Dawesh Prakash Yadav, Kumble Seetharama Madhusudhan, Saurabh Kedia, Raju Sharma, Venigalla Pratap Mouli, Sawan Bopanna, Rajan Dhingra, Rajesh Pradhan, Sandeep Goyal, Vishnubhatla Sreenivas, Naval K Vikram, Govind Makharia, Vineet Ahuja
  Journal of Gastroenterology and Hepatology.2017; 32(2): 420.     CrossRef
• Imaging of the small intestine in Crohn’s disease: Joint position statement of the Indian Society of Gastroenterology and Indian Radiological and Imaging Association
  Saurabh Kedia, Raju Sharma, Govind K. Makharia, Vineet Ahuja, Devendra Desai, Devasenathipathy Kandasamy, Anu Eapen, Karthik Ganesan, Uday C. Ghoshal, Naveen Kalra, D. Karthikeyan, Kumble Seetharama Madhusudhan, Mathew Philip, Amarender Singh Puri, Sunil
  Indian Journal of Gastroenterology.2017; 36(6): 487.     CrossRef
• Intestinal tuberculosis and Crohn's disease: challenging differential diagnosis
  Jia Yi Ma, Jin Lu Tong, Zhi Hua Ran
  Journal of Digestive Diseases.2016; 17(3): 155.     CrossRef
• Change in the diagnosis of inflammatory bowel disease: a hospital-based cohort study from Korea
  Ho-Su Lee, Jaewon Choe, Hyo Jeong Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Yong Sik Yoon, Chang Sik Yu, Jin-Ho Kim, Suk-Kyun Yang
  Intestinal Research.2016; 14(3): 258.     CrossRef

Citations

Citations to this article as recorded by  

• Esophageal Cancer Initially Presenting as Severe Paraneoplastic Hypercalcemia Requiring Hemodialysis
  Hye Shin Ahn, Jong Min Yun, Yeong Bok Lee, Yu Mi Ko, Jung Eun Lee, Hye Sung Won, Sung Soo Kim, Young Ok Kim
  The Korean Journal of Gastroenterology.2015; 65(6): 361.     CrossRef

Citations

Citations to this article as recorded by  

• Comparative Study on Bowel Preparation Efficacy of Ascorbic Acid Containing Polyethylene Glycol by Adding Either Simethicone or 1 L of Water in Health Medical Examination Patients: A Prospective Randomized Controlled Study
  Se Hwan Yeo, Jae Hoon Kwak, Yeo Un Kim, Tae Ho Kwon, Jeong Bae Park, Jun Hyung Park, Yong Kook Lee, Yun Jeong Lim, Chang Heon Yang
  The Korean Journal of Gastroenterology.2016; 67(4): 189.     CrossRef

Citations

Citations to this article as recorded by  

• Clinical Outcome of Treatment with Infliximab in Crohn's Disease: A Single-Center Experience
  Yeon-Ju Kim, Jung-Wook Kim, Chang Kyun Lee, Hyun Jin Park, Jae-Jun Shim, Jae Young Jang, Suk Ho Dong, Hyo Jong Kim, Byung-Ho Kim, Young Woon Chang
  The Korean Journal of Gastroenterology.2013; 61(5): 270.     CrossRef

Citations

Citations to this article as recorded by  

• Usefulness of Polyp and Adenoma Detection Rate in the Proximal and Distal Colon
  Sung Youn Choi, Dong Il Park, Chang Kyun Lee, Jae Myung Cha, Suck Ho Lee, Young Whangbo, Chang Soo Eun, Dong Soo Han, Bo In Lee, Jeong Eun Shin
  The Korean Journal of Gastroenterology.2014; 63(1): 11.     CrossRef
• Correlation between Adenoma Detection Rate and Advanced Adenoma Detection Rate
  Shin Yeoung Lee, Nam Hee Kim, Hyun Beom Chae, Ki Joong Han, Tae Hoon Lee, Choel Min Jang, Kyung Mo Yoo, Yoon Suk Jung, Jung Ho Park, Hong Joo Kim, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Dong Il Park
  The Korean Journal of Gastroenterology.2014; 64(1): 18.     CrossRef
• The Correlation between Polyp Detection Rate and Adenoma Detection Rate: Mainly Determined by the Colon Segment
  Geom Seog Seo
  The Korean Journal of Gastroenterology.2014; 63(1): 1.     CrossRef

Citations

Citations to this article as recorded by  

• A Case of Hepatosplenic T-cell Lymphoma Diagnosed by Bone Marrow Examination
  Hee Jin So, Jin Kyung Lee, Young Jun Hong, Seok-Il Hong, Hye Jin Kang, Seung-Sook Lee, Yoon Hwan Chang
  Laboratory Medicine Online.2013; 3(2): 104.     CrossRef

Citations

Citations to this article as recorded by  

• The optimal bowel preparation intervals before colonoscopy: A randomized study comparing polyethylene glycol and low-volume solutions
  Vladimir Kojecky, Jan Matous, Radan Keil, Milan Dastych, Zdena Zadorova, Michal Varga, Radek Kroupa, Jiri Dolina, Miroslav Misurec, Ales Hep, Martin Griva
  Digestive and Liver Disease.2018; 50(3): 271.     CrossRef
• Comparative Study on Bowel Preparation Efficacy of Ascorbic Acid Containing Polyethylene Glycol by Adding Either Simethicone or 1 L of Water in Health Medical Examination Patients: A Prospective Randomized Controlled Study
  Se Hwan Yeo, Jae Hoon Kwak, Yeo Un Kim, Tae Ho Kwon, Jeong Bae Park, Jun Hyung Park, Yong Kook Lee, Yun Jeong Lim, Chang Heon Yang
  The Korean Journal of Gastroenterology.2016; 67(4): 189.     CrossRef
• Randomized Controlled Trial of Sodium Phosphate Tablets versus 2 L Polyethylene Glycol Solution for Bowel Cleansing prior to Colonoscopy
  Yun Ho Lee, Seong Yeon Jeong, You Sun Kim, Hye Jin Jung, Min Jung Kwon, Cheol Hun Kwak, Song I Bae, Jeong Seop Moon, Ji Won Kim, Su Hwan Kim, Kook Lae Lee
  The Korean Journal of Gastroenterology.2015; 65(1): 27.     CrossRef
• Importance of the Time Interval between Bowel Preparation and Colonoscopy in Determining the Quality of Bowel Preparation for Full-Dose Polyethylene Glycol Preparation
  Tae Kyung Kim, Hyung Wook Kim, Su Jin Kim, Jong Kun Ha, Hyung Ha Jang, Young Mi Hong, Su Bum Park, Cheol Woong Choi, Dae Hwan Kang
  Gut and Liver.2014; 8(6): 625.     CrossRef
• A Comparison of 2 L of Polyethylene Glycol and 45 mL of Sodium Phosphate versus 4 L of Polyethylene Glycol for Bowel Cleansing: A Prospective Randomized Trial
  Suh Eun Bae, Kyung-Jo Kim, Jun Bum Eum, Dong Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Jin-Ho Kim
  Gut and Liver.2013; 7(4): 423.     CrossRef
• A Clear Liquid Diet Is Not Mandatory for Polyethylene Glycol-Based Bowel Preparation for Afternoon Colonoscopy in Healthy Outpatients
  Yoon Suk Jung, Hyo Sun Seok, Dong Il Park, Chang Seok Song, Seong Eun Kim, Suck Ho Lee, Chang Soo Eun, Dong Soo Han, Yong Soo Kim, Chang Kyun Lee
  Gut and Liver.2013; 7(6): 681.     CrossRef
• Comparison of Bowel Preparation Quality between Clear-liquid Diet and No Diet Restriction
  Woo Shin Jeong, Dong Il Park, Hyo Sun Seok, Seong Eun Kim, Suck-Ho Lee, Chang Kyun Lee, Chang Soo Eun, Dong Soo Han
  Intestinal Research.2012; 10(3): 272.     CrossRef
• Comparison among Conventional 4 L Polyethylene Glycol, Split Method of 4 L Polyethylene Glycol and Combination of 2 L Polyethylene Glycol and Sodium Phosphate Solution for Colonoscopy Preparation
  So Young Jo, Nayoung Kim, Jung Won Lee, Ji Hwan Lim, Chiun Choi, Ilyoung Chon, Ho Kil, Bo Young Min, Young Sang Byoun, Ban Seok Lee, Sang Eon Jang, Hyun Kyung Park, Hyun Jin Jo, Cheol Min Shin, Sang Hyup Lee, Young Soo Park, Jin-Hyeok Hwang, Jin-Wook Kim,
  The Korean Journal of Gastroenterology.2012; 59(6): 414.     CrossRef